<SEC-DOCUMENT>0001213900-26-041597.txt : 20260408
<SEC-HEADER>0001213900-26-041597.hdr.sgml : 20260408
<ACCEPTANCE-DATETIME>20260408173009
ACCESSION NUMBER:		0001213900-26-041597
CONFORMED SUBMISSION TYPE:	S-3/A
PUBLIC DOCUMENT COUNT:		6
FILED AS OF DATE:		20260408
DATE AS OF CHANGE:		20260408

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			RenX Enterprises Corp.
		CENTRAL INDEX KEY:			0001959023
		STANDARD INDUSTRIAL CLASSIFICATION:	REFUSE SYSTEMS [4953]
		ORGANIZATION NAME:           	01 Energy & Transportation
		EIN:				871375590
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-3/A
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-293528
		FILM NUMBER:		26849164

	BUSINESS ADDRESS:	
		STREET 1:		100 BISCAYNE BLVD.
		STREET 2:		#1201
		CITY:			MIAMI
		STATE:			FL
		ZIP:			33132
		BUSINESS PHONE:		(646) 240-4235

	MAIL ADDRESS:	
		STREET 1:		100 BISCAYNE BLVD.
		STREET 2:		#1201
		CITY:			MIAMI
		STATE:			FL
		ZIP:			33132

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Safe & Green Development Corp
		DATE OF NAME CHANGE:	20221219
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-3/A
<SEQUENCE>1
<FILENAME>ea0285157-s3a1_renx.htm
<DESCRIPTION>AMENDMENT NO. 1 TO FORM S-3
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"> <B>As filed with the Securities and Exchange Commission on April 8,
2026</B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"> <B>Registration No. 333-293528</B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> <B>AMENDMENT NO. 1 TO</B> </P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-size: 12pt"><B>FORM
S-3</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>REGISTRATION STATEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>UNDER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>THE SECURITIES ACT OF 1933</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: center"><FONT STYLE="font-size: 12pt"><B>RenX Enterprises
    Corp.</B></FONT></TD></TR>
  <TR>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">(Exact name of registrant as specified in its charter)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 49%; font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>Delaware</B></FONT></TD>
    <TD STYLE="text-align: center; width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 49%; font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>87-1375590</B></FONT></TD></TR>
  <TR>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">(State or other jurisdiction of</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">(I.R.S. Employer</FONT></TD></TR>
  <TR>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">incorporation or organization)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">Identification Number)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>100 Biscayne Blvd., #1201</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Miami, Florida 33132</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"> <B>(786) 808-5776</B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Address, including zip code, and telephone number,
including area code, of registrant&rsquo;s principal executive offices)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>David Villarreal</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Chief Executive Officer</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>100 Biscayne Blvd., #1201</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Miami, Florida 33132</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"> <B>(786) 808-5776</B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"> (Name, address, including
zip code, and telephone number, including area code, of agent for service) </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><I>Copy to:</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Leslie Marlow,&nbsp;Esq.<BR>
Melissa Palat Murawsky,&nbsp;Esq.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Blank Rome LLP</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>1271 Avenue of the Americas</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>New York, New York 10020</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Telephone: (212) 885-5000</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Facsimile: (212) 885-5001</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Approximate date of commencement of proposed
sale to the public:</B> From time to time after the effective date of this registration statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If the only securities being registered on this
Form are being offered pursuant to dividend or interest reinvestment plans, please check the following box: <FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If any of the securities being registered on this
Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, other than securities offered
only in connection with dividend or interest reinvestment plans, check the following box: <FONT STYLE="font-family: Times New Roman, Times, Serif">&#9746;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If this Form is filed to register additional securities
for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration
statement number of the earlier effective registration statement for the same offering: <FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If this Form is a post-effective amendment filed
pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of
the earlier effective registration statement for the same offering. <FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If this Form is a registration statement pursuant
to General Instruction I.D. or a post-effective amendment thereto that shall become effective upon filing with the Commission pursuant
to Rule 462(e) under the Securities Act, check the following box. <FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If this Form is a post-effective amendment to
a registration statement filed pursuant to General Instruction I.D. filed to register additional securities or additional classes of securities
pursuant to Rule 413(b) under the Securities Act, check the following box. <FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.
See the definitions of &ldquo;large accelerated filer,&rdquo; &ldquo;accelerated filer,&rdquo; &ldquo;smaller reporting company,&rdquo;
and &ldquo;emerging growth company&rdquo; in Rule 12b-2 of the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; width: 30%; text-align: justify"><FONT STYLE="font-size: 10pt">Large accelerated filer</FONT></TD>
    <TD STYLE="width: 20%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 30%; text-align: justify"><FONT STYLE="font-size: 10pt">Accelerated filer</FONT></TD>
    <TD STYLE="width: 20%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-size: 10pt">Non-accelerated filer</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-size: 10pt">Smaller reporting company</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-size: 10pt">Emerging growth company</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. <FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The Registrant hereby amends this registration
statement on such date or dates as may be necessary to delay its effective date until the Registrant shall file a further amendment that
specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of the Securities
Act of 1933, as amended, or until the registration statement shall become effective on such date as the Securities and Exchange Commission,
acting pursuant to said Section 8(a), may determine.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 33.75pt">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 33.75pt"></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="color: Red"><B>The
information in this prospectus is not complete and may be changed. The Selling Stockholders named in this prospectus may not sell these
securities until the registration statement filed with the Securities and Exchange Commission is effective. This prospectus is not an
offer to sell these securities and the Selling Stockholders named in this prospectus are not soliciting offers to buy these securities
in any state or other jurisdiction where the offer or sale is not permitted.</B></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"> <FONT STYLE="color: Red"><B>Subject
to completion, dated April 8, 2026</B></FONT> </P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>PRELIMINARY PROSPECTUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><IMG SRC="ea028515701_img1.jpg" ALT=""></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> <B>2,290,312 Shares of Common Stock</B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> This prospectus relates to the resale by the
selling stockholders named in this prospectus (the &ldquo;Selling Stockholders&rdquo;) from time to time of up to 2,290,312 shares of
our common stock, par value $0.001 per share (the &ldquo;Common Stock&rdquo;), of RenX Enterprises Corp. (the &ldquo;Company,&rdquo;
&ldquo;we,&rdquo; &ldquo;our,&rdquo; or &ldquo;us&rdquo;). The shares of Common Stock being registered herewith consist of: (i) up to
an aggregate of 1,215,048 shares of Common Stock issuable upon the conversion of those certain senior convertible notes in the aggregate
principal amount of $6,042,985.39 (the &ldquo;Notes&rdquo;) that we issued to the Selling Stockholders on February 17, 2026 pursuant
to that securities purchase agreement, dated February 12, 2026 (the &ldquo;Purchase Agreement&rdquo;), by and between us and the Selling
Stockholders, as more fully described in this prospectus, and (ii) up to 1,075,264 shares of Common Stock (the &ldquo;First Warrant Shares&rdquo;)
issuable upon exercise of certain accompanying warrants (the &ldquo;First Warrants&rdquo;) that were issued to the Selling Stockholders
together with the Notes pursuant to the Purchase Agreement. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> The 1,215,048 shares of Common Stock issuable
upon conversion of the Notes (the &ldquo;Conversion Shares&rdquo;) assumes the full conversion of the Notes, plus accrued interest in
full into Common Stock, at the conversion price of $5.62 per share (assuming the Notes accrued interest at 12% for a period of thirteen
(13) months), without giving effect to any default interest or penalties which may accrue thereunder and without regard to any conversion
limitations set forth in the Notes. The First Warrants are exercisable immediately upon issuance, have a term of six years from the date
of issuance and are exercisable at a price of $3.1188 per share of Common Stock. The Conversion Shares and the First Warrant Shares are
collectively referred to as (the &ldquo;Private Placement Shares&rdquo;). </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> The Notes and the First Warrants were issued
in reliance upon the exemption from the registration requirements in Section 4(a)(2) of the Securities Act of 1933, as amended (the &ldquo;Securities
Act&rdquo;), and/or Regulation D promulgated thereunder, as applicable. We are registering the Private Placement Shares for resale by
the Selling Stockholders. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are filing this registration statement on Form
S-3, of which this prospectus forms a part, to fulfill our contractual obligations to register the resale of the Private Placement Shares
by the Selling Stockholders. See &ldquo;Selling Stockholders&rdquo; beginning on page 13 of this prospectus for more information about
the Selling Stockholders. Our registration of the shares of Common Stock covered by this prospectus does not mean that the Selling Stockholders
will offer or sell any of such shares of Common Stock. The Selling Stockholders named in this prospectus, or their donees, pledgees, transferees
or other successors-in-interest, may resell the shares of Common Stock covered by this prospectus through public or private transactions
at prevailing market prices, at prices related to prevailing market prices or at privately negotiated prices. For additional information
on the possible methods of sale that may be used by the Selling Stockholders, you should refer to the section of this prospectus entitled
&ldquo;Plan of Distribution.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> The issuance of the shares of Common Stock
covered by this prospectus could cause substantial dilution to our existing stockholders. The number of shares covered by this prospectus
represents approximately 91% of the number of shares of Common Stock issued and outstanding as of the date of this prospectus. The actual
number of shares of Common Stock that we issue to the Selling Stockholders may be less than the aggregate number of shares covered by
this prospectus. Please refer to risk factor entitled &ldquo;<I>The issuance of all of the shares of Common Stock covered by this prospectus
will significantly increase the total number of shares of Common Stock issued and outstanding and thereby cause our existing stockholders
to experience substantial dilution</I>&rdquo; on page 5 of this prospectus. For additional information regarding the terms of the Notes
and the First Warrants, including those terms which may affect the number of Conversion Shares and First Warrant Shares that may be issued
to the holders of the Notes and the First Warrants, you should refer to the section of this prospectus entitled &ldquo;The Private Placement.&rdquo; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> We will not receive any of the proceeds from
the sale of Common Stock by the Selling Stockholders. However, we will receive proceeds from the exercise of the First Warrants, if the
First Warrants are exercised by the Selling Stockholders for cash. We intend to use those proceeds, if any, for general corporate purposes. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any Private Placement Shares subject to resale
hereunder will have been issued by us and acquired by the Selling Stockholders prior to any resale of such shares pursuant to this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">No underwriter or other person has been engaged
to facilitate the sale of the Private Placement Shares in this offering. We will bear all costs, expenses and fees in connection with
the registration of the Private Placement Shares. The Selling Stockholders will bear all commissions and discounts, if any, attributable
to their respective sales of the Private Placement Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> Shares of our Common Stock are traded on the
Nasdaq Capital Market (&ldquo;Nasdaq&rdquo;) under the symbol &ldquo;RENX.&rdquo; On April 6, 2026, the closing sale price of our Common
Stock on Nasdaq was $2.41 per share. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are an &ldquo;emerging growth company&rdquo;
and a &ldquo;smaller reporting company,&rdquo; each as defined under the federal securities laws and, as such, have elected to comply
with certain reduced reporting requirements for this prospectus and may elect to do so in future filings. See the sections of this prospectus
entitled &ldquo;Prospectus Summary - Implications of Being an Emerging Growth Company&rdquo; and &ldquo;Prospectus Summary &ndash; Implications
of Being a Smaller Reporting Company.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We may amend or supplement this prospectus from
time to time by filing amendments or supplements as required. You should read the entire prospectus and any amendments or supplements
carefully before you make an investment decision.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Investment in our Common Stock involves risk.
See &ldquo;Risk Factors&rdquo; contained in this prospectus on page 4, under similar headings in our annual and periodic reports filed
from time to time with the Securities and Exchange Commission, which are incorporated by reference in this prospectus and in any applicable
prospectus supplement. You should carefully read this prospectus and the accompanying prospectus supplement, together with the documents
we incorporate by reference, before you invest in our Common Stock.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Neither the Securities and Exchange Commission
nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or the accuracy of this
prospectus. Any representation to the contrary is a criminal offense.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"> The date of this prospectus
is&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
, 2026. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>TABLE OF CONTENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="width: 90%"><A HREF="#ren_001">ABOUT THIS PROSPECTUS</A></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="text-align: center; width: 9%">ii</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><A HREF="#ren_002">PROSPECTUS SUMMARY</A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">1</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#ren_003">THE OFFERING</A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">3</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><A HREF="#ren_004">RISK FACTORS</A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">4</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#ren_005">SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS</A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">7</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><A HREF="#ren_006">THE PRIVATE PLACEMENT</A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">8</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#ren_007">USE OF PROCEEDS</A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">12</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><A HREF="#ren_008">SELLING STOCKHOLDERS</A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">13</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#ren_009">PLAN OF DISTRIBUTION</A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">15</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><A HREF="#ren_010">LEGAL MATTERS</A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">16</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#ren_011">EXPERTS</A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">16</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><A HREF="#ren_012">WHERE YOU CAN FIND MORE INFORMATION</A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">16</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#ren_013">INFORMATION OF CERTAIN DOCUMENTS BY REFERENCE</A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">17</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The registration statement containing this
prospectus, including the exhibits to the registration statement, provides additional information about us and the Common Stock offered
under this prospectus. The registration statement, including the exhibits, can be read on our website and the website of the Securities
and Exchange Commission. See &ldquo;Where You Can Find More Information.&rdquo;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Information contained in, and that can be accessed
through our web site,<I>&nbsp;www.renxent.com,</I>&nbsp;shall not be deemed to be part of this prospectus or incorporated herein by reference
and should not be relied upon by any prospective investors for the purposes of determining whether to purchase the Common Stock offered
hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Unless the context otherwise requires, the terms
&ldquo;&ldquo;we,&rdquo; &ldquo;us,&rdquo; &ldquo;our,&rdquo; &ldquo;the Company,&rdquo; &ldquo;RenX&rdquo; and &ldquo;our business&rdquo;
refer to RenX Enterprises Corp. and &ldquo;this offering&rdquo; refers to the offering contemplated in this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><A NAME="ren_001"></A><B>ABOUT THIS PROSPECTUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This prospectus is part of a registration statement
on Form&nbsp;S-3 that we filed with the U.S.&nbsp;Securities and Exchange Commission (the &ldquo;SEC&rdquo;). Under this registration
process, the Selling Stockholders may, from time to time, sell the securities offered by them described in this prospectus. We will not
receive any proceeds from the sale by the Selling Stockholders of the Private Placement Shares offered by them described in this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">This prospectus provides
you with a general description of the Private Placement Shares that the Selling Stockholders may offer. A prospectus supplement may also
add, update or change information contained in this prospectus. To the extent that any statement made in an accompanying prospectus supplement
is inconsistent with statements made in this prospectus, the statements made in this prospectus will be deemed modified or superseded
by those made in the accompanying prospectus supplement. You should read both this prospectus and any accompanying prospectus supplement
together with the additional information described under the headings &ldquo;Where You Can Find More Information&rdquo; and &ldquo;Incorporation
of Certain Documents by Reference.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Neither we nor the Selling Stockholders have authorized
anyone to provide you with any information or to make any representations other than those contained, or incorporated by reference, in
this prospectus, any post-effective amendment, or any applicable prospectus supplement or free-writing prospectus prepared by or on behalf
of us or to which we have referred you. We and the Selling Stockholders take no responsibility for and can provide no assurance as to
the reliability of any other information that others may give you. This prospectus is an offer to sell only the Private Placement Shares
offered hereby, but only under circumstances and in jurisdictions where it is lawful to do so. You should not assume that the information
contained in this prospectus or any applicable prospectus supplement is accurate on any date subsequent to the date set forth on the front
of the document or that any information we have incorporated by reference is correct on any date subsequent to the date of the document
incorporated by reference, even though this prospectus or any applicable prospectus supplement is delivered, or securities are sold, on
a later date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This prospectus contains summaries of certain
provisions contained in some of the documents described herein, but reference is made to the actual documents for complete information.
All of the summaries are qualified in their entirety by the actual documents. Copies of some of the documents referred to herein have
been filed, will be filed or will be incorporated by reference as exhibits to the registration statement of which this prospectus is a
part, and you may obtain copies of those documents as described below under the section entitled &ldquo;Where You Can Find More Information.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This prospectus and the information incorporated
herein by reference include trademarks, service marks and trade names owned by us or other companies. All trademarks, service marks and
trade names included or incorporated by reference into this prospectus, any applicable prospectus supplement or any related free writing
prospectus are the property of their respective owners.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 8pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<DIV STYLE="padding: 5.4pt; border: Black 1.5pt solid">

<P STYLE="font: 8pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><A NAME="ren_002"></A>PROSPECTUS SUMMARY</B></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>This summary highlights certain information
about us and selected information contained elsewhere in this prospectus and in the documents we incorporate by reference. This summary
does not contain all of the information you should consider before investing in our Common Stock. You should read this entire prospectus
and the documents incorporated by reference carefully, especially the risks of investing in our Common Stock discussed under and incorporated
by reference in &ldquo;Risk Factors&rdquo; on page&nbsp;4 of this prospectus, along with our consolidated financial statements and
notes to those consolidated financial statements and the other information incorporated by reference in this prospectus, before making
an investment decision.</I></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> On October&nbsp;8, 2024, we effected a 1-for-20&nbsp;reverse
stock split of our then-outstanding&nbsp;Common Stock (the &ldquo;2024 Stock Split&rdquo;). All share and per share amounts set forth
in this prospectus from the period prior to the 2024 Stock Split have been retroactively adjusted to reflect the 2024 Stock Split. </P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> On March 26, 2026, we effected a 1-for-20
reverse stock split of our then-outstanding Common Stock (the &ldquo;2026 Stock Split&rdquo;). All share and per share amounts set forth
in this prospectus from the period prior to the 2026 Stock Split have been retroactively adjusted to reflect the 2026 Stock Split. </P>
<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The Company</B></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">RenX Enterprises Corp. is a Delaware corporation,
originally formed in 2021 under the name SGB Development Corp., to engage in real property development using purpose-built, prefabricated
modules constructed from both wood and steel. From our inception through 2023, our operations primarily focused on the acquisition, entitlement,
and development of residential properties in high-growth&nbsp;markets across the United&nbsp;States. These efforts included the direct
acquisition of land, strategic investments in real estate entities, and joint venture partnerships targeting green, single-family&nbsp;and
multifamily housing projects.</P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> In 2023 and early 2024, we expanded our strategy
by investing in real estate-related&nbsp;artificial intelligence (&ldquo;AI&rdquo;) technologies and entering into additional joint ventures
in the Southern Texas market aimed at developing sustainable single-family&nbsp;housing. Due to our shift in focus described below, we
are no longer pursuing real estate AI related activities.&nbsp;We also announced plans to monetize our real estate holdings by selling
properties where third-party&nbsp;appraisals indicated meaningful value appreciation, with proceeds to be reinvested into our current
operations. </P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> In June&nbsp;2025, we completed our acquisition
of Resource Group US Holdings LLC (&ldquo;Resource Group&rdquo;), which marked a significant strategic shift in our core business. Resource
Group, through its subsidiaries, is a vertically integrated, full-service&nbsp;operator in the engineered soils and organic recycling
industry. Its operations center on the transformation of targeted organic green waste materials into environmentally friendly soil and
mulch products. Through our subsidiary, Zimmer Equipment Inc. (&ldquo;ZEI&rdquo;), we provide comprehensive waste logistics and collection
services for our own products as well as for products of third parties through ZEI&rsquo;s owned fleet of high-capacity transportation
equipment and third-party contractors engaged by us. ZEI offers year-round collection and disposal services through high-capacity grapple
trucks, open-top walking floor trailers, and variable-sized containers serving green waste generators, landscaping companies, golf courses,
communities, and municipalities. Resource Group works with ZEI to streamline operations by internalizing certain transportation services,
reducing over-the-road mileage, lowering disposal costs, and maximizing efficiency. </P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> We currently operate in three segments: biomass
recycling, logistics, and real estate. While our logistics business operated by our subsidiary, ZEI, and our biomass recycling business
operated by our subsidiary, Resource Group, are expected to serve as our primary operational focuses going forward, we also currently
intend to continue to monetize our legacy real estate assets and joint venture interests. </P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>Risks Associated with
this Offering</B></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Our business and our
ability to implement our business strategy are subject to numerous risks, as more fully described in the section of this prospectus entitled
&ldquo;Risk Factors&rdquo; and under similarly titled headings of the documents incorporated herein by reference. You should read these
risks befo<FONT STYLE="font-family: Times New Roman, Times, Serif">re you invest in our securities. We may be unable, for many reasons,
including those that are beyond our control, to implement our business strategy. In particular, risks associated with this offering include:</FONT></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">If
                                            we fail to comply with the continued listing requirements of Nasdaq, our Common Stock may
                                            be delisted and the price of our Common Stock and our ability to access the capital markets
                                            could be negatively impacted.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">It
                                            is not possible to predict the actual number of shares of Common Stock we will issue upon
                                            conversion of the Notes.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
                                            sale of a substantial amount of our shares in the public market could adversely affect the
                                            prevailing market price of our securities.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
                                            issuance of the shares of Common Stock covered by this prospectus could significantly increase
                                            the total number of shares of Common Stock issued and outstanding and thereby cause our existing
                                            stockholders to experience substantial dilution.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Under
                                            the Purchase Agreement, we are subject to certain restrictive covenants that may make it
                                            difficult to procure additional financing.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Investors
                                            who buy shares at different times will likely pay different prices.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
                                            have additional securities available for issuance, which, if issued, could adversely affect
                                            the rights of the holders of our Common Stock.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Stockholders
                                            may experience significant dilution as a result of potential future financings that we may
                                            effect.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 6; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></P>

<DIV STYLE="padding: 5.4pt; border: Black 1.5pt solid">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">An
                                            active trading market for our Common Stock may not be sustained.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
                                            share price may be subject to substantial volatility, and stockholders may lose all or a
                                            substantial part of their investment.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Implications
of Being an Emerging Growth Company</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
are an &ldquo;emerging growth company&rdquo; as defined in the federal securities laws. An emerging growth company may take advantage
of specified reduced reporting requirements that are otherwise generally applicable to public companies. As a result:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">we
                                            are required to have only two years of audited financial statements and only two years of
                                            management&rsquo;s discussion and analysis of financial condition and results of operation
                                            in this prospectus;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">we
                                            are not required to comply with any requirement that may be adopted by the Public Company
                                            Accounting Oversight Board regarding mandatory audit firm rotation or a supplement to the
                                            auditor&rsquo;s report providing additional information about the audit and financial statements
                                            (i.e., an auditor discussion and analysis) compliance with new or revised accounting standards
                                            until they are made applicable to private companies;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">we
                                            are not required to engage an auditor to provide an attestation to report on our internal
                                            control over financial reporting pursuant to Section 404(b) of the Sarbanes-Oxley Act of
                                            2002;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">we
                                            are not required to comply with certain disclosure requirements related to executive compensation,
                                            such as the requirement to disclose the correlation between executive compensation and performance
                                            and the requirement to present a comparison of our Chief Executive Officer&rsquo;s compensation
                                            to our median employee compensation; and</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">we
                                            are not required to submit certain executive compensation matters to stockholder advisory
                                            votes, such as &ldquo;say on pay,&rdquo; &ldquo;say on frequency&rdquo; and &ldquo;say on
                                            golden parachute arrangements.&rdquo;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
may take advantage of these reduced reporting and other requirements until the earlier of (i) the last day of the first fiscal year following
the fifth anniversary of the completion of this offering; (ii) the last day of the first fiscal year in which we have total annual gross
revenue of at least $1.235 billion; (iii) the last day of the fiscal year in which we are deemed to be a &ldquo;large accelerated filer&rdquo;
as defined in Rule 12b-2 under the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;), which would occur if
the market value of our common stock held by non-affiliates exceeded $700.0 million as of the last business day of the second fiscal
qu</FONT>arter of such fiscal year; or (iv) the date on which we have issued more than $1.0 billion in non-convertible debt securities
during the prior three-year period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">We have elected to take
advantage of certain of the reduced disclosure obligations in this prospectus and the registration statement of which this prospectus
is a part, and we may elect to take advantage of other reduced reporting requirements in the future. As a result, the information that
we provide to our stockholders may be different than, and not comparable to, information presented by other public reporting companies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>Implications of Being a Smaller Reporting
Company</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">We are also a &ldquo;smaller
reporting company&rdquo; as defined in Rule 10(f)(1) of Regulation S-K. Smaller reporting companies may take advantage of certain reduced
disclosure obligations, including, among other things, providing only two years of audited financial statements. We will remain a smaller
reporting company until the last day of the fiscal year in which (1) the market value of our shares held by non-affiliates equals or exceeds
$250 million as of the prior June 30th, or (2) our annual revenues equaled or exceeded $100 million during such completed fiscal year
and the market value of our shares held by non-affiliates equals or exceeds $700 million as of the prior June 30th. Such reduced disclosure
and corporate governance obligations may make it more challenging for investors to analyze our results of operations and financial prospects.
We may be a smaller reporting company even after we are no longer an emerging growth company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Corporate Information</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> We were incorporated in Delaware on February
27, 2021. Our principal executive office is located at 100 Biscayne Blvd., Floor&nbsp;12, Suite 1201, Miami, Florida 33132, and our phone
number is (786) 808-5776. We maintain a website at&nbsp;<I>www.renxent.com</I>. The reference to our website is intended to be an inactive
textual reference only. The information contained on, or that can be accessed through, our website is not part of this prospectus. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> In December 2022, Safe &amp; Green Holdings
Corp. (&ldquo;SG Holdings&rdquo;), the then owner of 100% of our issued and outstanding securities, announced its plan to separate Safe
and Green Development and SG Holdings into two separate publicly traded companies (the &ldquo;Separation&rdquo;). To implement the Separation,
on September 27, 2023 (the &ldquo;Distribution Date&rdquo;), SG Holdings, effected a pro rata distribution to SG Holdings&rsquo; stockholders
of approximately 30% of the outstanding shares of our Common Stock (the &ldquo;Distribution&rdquo;). Immediately after the Distribution,
we were no longer a wholly owned subsidiary of SG Holdings and SG Holdings held approximately 70% of our issued and outstanding securities.
SG Holdings no longer holds any of our issued and outstanding securities. On September 28, 2023, our Common Stock began trading on the
Nasdaq Capital Market under the symbol &ldquo;SGD.&rdquo; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Effective December 19, 2025, we changed our corporate
name to RenX Enterprises Corp. and our Common Stock began trading on the Nasdaq Capital Market under the symbol &ldquo;RENX.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></P>

<DIV STYLE="padding: 5.4pt; border: Black 1.5pt solid">

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="ren_003"></A><B>THE OFFERING</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> This prospectus relates to the resale or other
disposition from time to time by the Selling Stockholders identified in this prospectus of up to 2,290,312 Private Placement Shares.
None of the Private Placement Shares registered for resale hereby are being offered for sale by us. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 25%"> <B>Shares of Common Stock outstanding prior to this offering</B> </TD>
    <TD STYLE="width: 1%; text-align: justify"> &nbsp; </TD>
    <TD STYLE="width: 74%; text-align: justify"> <FONT STYLE="font-size: 10pt">2,507,537 shares</FONT> </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD> <B>Shares of Common Stock offered by the Selling Stockholders</B> </TD>
    <TD STYLE="text-align: justify"> &nbsp; </TD>
    <TD STYLE="text-align: justify"> <FONT STYLE="font-size: 10pt">2,290,312 shares of our Common Stock, consisting of: (i) &nbsp;1,215,048
    shares of Common Stock issuable upon the conversion of the Notes, assuming the full conversion of the Notes plus accrued interest
    in full into Common Stock, at the conversion price of $5.62 per share (assuming the Notes accrued interest at 12% for a period of
    thirteen (13) months), without giving effect to any default interest or penalties which may accrue thereunder and without regard
    to any conversion limitations set forth in the Notes; and (ii) 1,075,264 shares of Common Stock issuable upon exercise of the First
    Warrants.</FONT> </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt"><B>Terms of the offering</B></FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The Selling Stockholders and any of their pledgees, assignees and successors-in-interest will determine when and how they sell the Private Placement Shares offered in this prospectus and may, from time to time, sell any or all of their shares covered hereby on Nasdaq or any other stock exchange, market or trading facility on which the shares are traded or in privately negotiated transactions. These sales may be at fixed or negotiated prices. See &ldquo;Plan of Distribution.&rdquo; &nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD> <FONT STYLE="font-size: 10pt"><B>Common Stock outstanding after this offering</B></FONT> </TD>
    <TD STYLE="text-align: justify"> &nbsp; </TD>
    <TD STYLE="text-align: justify"> 4,797,849 </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><B>Registration Rights &nbsp;</B></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">In connection with the Private Placement, we entered into a registration rights agreement (the &ldquo;Registration Rights Agreement&rdquo;), dated as of February 12, 2026, with each of the Selling Stockholders. Under the terms of the Registration Rights Agreement, we agreed to prepare and file this registration statement with respect to the registration of the Private Placement Shares by the Selling Stockholders by the 30th calendar day following the closing date and to use commercially reasonable efforts to have the registration statement declared effective as promptly as possible thereafter. The Registration Rights Agreement further provides that we shall use commercially reasonable efforts to keep such registration statement effective at all times until all securities covered by such registration statement have been sold or may be sold without volume or manner-of-sale restrictions pursuant to Rule&nbsp;144 and without the requirement for us to be in compliance with the current public information requirement under Rule&nbsp;144.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD> <FONT STYLE="font-size: 10pt"><B>Use of Proceeds</B></FONT> </TD>
    <TD STYLE="text-align: justify"> &nbsp; </TD>
    <TD STYLE="text-align: justify"> <FONT STYLE="font-size: 10pt">The Selling Stockholders will receive all of the proceeds from the
    sale of any Private Placement Shares sold by them pursuant to this prospectus. We will not receive any proceeds from the sale of
    the Private Placement Shares by the Selling Stockholders (although we may receive proceeds from the exercise of the First Warrants,
    to the extent such Warrants are exercised for cash by the Selling Stockholders). See &ldquo;<I>Use of Proceeds</I>&rdquo; in this
    prospectus.</FONT> </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt"><B>Risk Factors</B></FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">You should read the &ldquo;Risk Factors&rdquo; section of this prospectus and in the documents incorporated by reference in this prospectus for a discussion of factors to consider before deciding to purchase shares of our Common Stock.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt"><B>Nasdaq symbol</B></FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Shares of our Common Stock are listed on Nasdaq under the symbol &ldquo;RENX.&rdquo;</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> Except as otherwise indicated, the number
of shares of Common Stock to be outstanding immediately after this offering is based on 2,507,537 shares of Common Stock outstanding
as of April 8, 2026, and excludes: </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"> &nbsp; </TD>
    <TD STYLE="width: 0.25in"> <FONT STYLE="font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify"> 47,327 shares of Common Stock issuable upon the exercise of warrants outstanding at a weighted
    average exercise price of $18.188 per share, which excludes the First Warrant Shares; </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify"> <FONT STYLE="font-size: 10pt">101,298 shares of Common Stock issuable upon the conversion of 337,811
    outstanding shares of Series A Convertible Preferred Stock (the &ldquo;Series A Preferred Stock&rdquo;);</FONT> </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify"> 2,048 shares of Common Stock issuable upon the conversion of 551 outstanding shares of Series
    B Non-Voting Convertible Preferred Stock (the &ldquo;Series B Preferred Stock&rdquo;); </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify"> 16,000 shares of Common Stock issuable upon the exercise of options outstanding at a weighted
    average exercise price of $5.40]per share; and </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify"> 92,924 shares of Common Stock reserved for future issuance under the Company&rsquo;s 2023 Incentive
    Compensation Plan (the &ldquo;2023 Plan&rdquo;). </TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> Unless otherwise indicated, all information contained in this prospectus
assumes no exercise of the outstanding warrants or options, no conversion of the outstanding shares of Series A Preferred Stock and Series
B Preferred Stock and no settlement of outstanding restricted stock units described in the bullets above. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 8pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><A NAME="ren_004"></A><B>RISK FACTORS</B></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Investing in our shares of Common Stock involves
a high degree of risk. Before deciding whether to invest in our Common Stock, you should consider carefully the risks and uncertainties
described below, together with all of the other information included or incorporated by reference in this prospectus, including the risks
and uncertainties discussed under &ldquo;Risk Factors&rdquo; in our most recent Annual Report on Form 10-K and our subsequent Quarterly
Reports on Form 10-Q, which are incorporated by reference in this prospectus, as well as any updates thereto contained in subsequent filings
with the SEC or any free writing prospectus, before deciding whether to purchase our Common Stock in this offering. All of these risk
factors are incorporated herein in their entirety. The risks described below and incorporated by reference are material risks currently
known, expected or reasonably foreseeable by us. However, the risks described below and incorporated by reference are not the only ones
that we face. Additional risks not presently known to us or that we currently deem immaterial may also affect our business, operating
results, prospects or financial condition. If any of these risks actually materialize, our business, prospects, financial condition, and
results of operations could be seriously harmed. This could cause the trading price of our Common Stock to decline, resulting in a loss
of all or part of your investment. For more information, see the section entitled &ldquo;Where You Can Find More Information.&rdquo;</I></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>If we fail to comply with the continued
listing requirements of Nasdaq, our Common Stock may be delisted and the price of our Common Stock and our ability to access the capital
markets could be negatively impacted.</I></B></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Common Stock is currently listed for trading
on Nasdaq. We must satisfy Nasdaq&rsquo;s continued listing requirements, including, among other things, a minimum stockholders&rsquo;
equity of&thinsp;$2.5 million and a minimum closing bid price of $1.00 per share or risk delisting, which would have a material adverse
effect on our business. A delisting of our Common Stock from Nasdaq could materially reduce the liquidity of our Common Stock and result
in a corresponding material reduction in the price of our Common Stock. In addition, delisting could harm our ability to raise capital
through alternative financing sources on terms acceptable to us, or at all, and may result in the potential loss of confidence by investors,
suppliers, customers and employees and fewer business development opportunities.</P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> On January 26, 2026, we received a letter
from Nasdaq notifying us that for the preceding 30 consecutive business days (December 5, 2025 through January 20, 2026), our Common
Stock did not maintain a minimum closing bid price of $1.00 per share as required by Nasdaq Listing Rule 5550(a)(2) (&ldquo;Minimum Bid
Price Requirement&rdquo;). The notice had no immediate effect on the listing or trading of our Common Stock, which continues to trade
on the Nasdaq Capital Market under the symbol &ldquo;RENX.&rdquo; In accordance with Nasdaq Listing Rule 5810(c)(3)(A), we have a compliance
period of 180 calendar days, or until July 27, 2026, to regain compliance with Nasdaq Listing Rule 5550(a)(2). On December 8, 2025, our
stockholders approved and authorized us to amend our Amended and Restated Certificate of Incorporation, as amended, to effect a reverse
stock split at a ratio of 1-for-5 to 1-for-20, and on March 26, 2026, we effected the 1-for-20 reverse stock split of our then-outstanding
Common Stock. Nasdaq Listing Rule 5810(c)(3)(A)(iv) states that any listed company that fails to meet the Minimum Bid Price Requirement
and has effected a reverse stock split over the prior one-year period, or has effected one or more reverse stock splits over the prior
two-year period with a cumulative ratio of 250 shares or more to one, will not be eligible for an automatic 180-day grace compliance
period and the Nasdaq Listing Qualifications Department is obligated to immediately issue a delisting determination if it should fail
to meet any continued listing requirements. Therefore, if we were to fail to meet any continued listing requirements we would immediately
be issued a delisting determination. Further, the Nasdaq rule provides that a company will not be considered to have regained compliance
with the minimum bid price requirement if the company takes an action to achieve compliance (such as a reverse split) and that action
results in the Company&rsquo;s security falling below the numeric threshold for another listing requirement. </P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> As of April 8, 2026, the closing bid price
of our Common Stock has been over $1.00 per share for nine consecutive trading days since we completed the 2026 Stock Split for the purpose
of regaining compliance with the Minimum Bid Price Requirement. In order to regain compliance with the Minimum Bid Price Requirement,
the closing bid price of our Common Stock must be $1.00 per share or greater for a minimum period of 10 consecutive trading days (which
may be subject to extension by Nasdaq, in their discretion) after completion of the 2026 Stock Split. There can be no assurance that
we will be able to regain compliance with the Minimum Bid Price Requirement within the applicable compliance period or at all. </P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> Additionally, Nasdaq has recently proposed a new rule change to (i)
adopt Listing Rules 5450(a)(3) and 5550(a)(6) to require issuers listed on the Nasdaq Global and Capital Markets, respectively, to maintain
a minimum Market Value of Listed Securities (as defined in Nasdaq Listing Rule 5005(a)(23)) of at least $5 million for a period of 30
consecutive business days, and (ii) amend Rule 5810 to suspend trading and immediately delist from Nasdaq securities of issuers that do
not satisfy the proposed new requirements, and Rule 5815 to set forth the procedures for requesting a hearing before a Hearings Panel
and the scope of the Panel&rsquo;s discretion (collectively, the &ldquo;Proposed $5 Million MVLS Rule&rdquo;). As of April 8, 2026, the
market value of our listed securities is less than $5 million. If the SEC approves the Proposed $5 Million MVSL Rule and the market value
of our listed securities does not meet the $5.0 million requirement as of the date it goes into effect, our securities will be subject
to delisting. </P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I></I></B></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> There is no assurance that we will regain
and/or maintain compliance with all applicable requirements for continued listing on Nasdaq. If our Common Stock were delisted from Nasdaq,
trading of our Common Stock would most likely take place on an over-the-counter market established for unlisted securities, such as the
OTCQB or the Pink Market maintained by OTC Markets Group Inc. An investor would likely find it less convenient to sell, or to obtain
accurate quotations in seeking to buy, our Common Stock on an over-the-counter market, and many investors would likely not buy or sell
our Common Stock due to difficulty in accessing over-the-counter markets, policies preventing them from trading in securities not listed
on a national exchange or other reasons. In addition, as a delisted security, our Common Stock would be subject to SEC rules as a &ldquo;penny
stock,&rdquo; which impose additional disclosure requirements on broker-dealers. The regulations relating to penny stocks, coupled with
the typically higher cost per trade to the investor of penny stocks due to factors such as broker commissions generally representing
a higher percentage of the price of a penny stock than of a higher-priced stock, would further limit the ability of investors to trade
in our Common Stock. In addition, delisting could harm our ability to raise capital through alternative financing sources on terms acceptable
to us, or at all, and may result in the potential loss of confidence by investors, suppliers, customers and employees and fewer business
development opportunities. For these reasons and others, delisting would adversely affect the liquidity, trading volume and price of
our Common Stock, causing the value of an investment in us to decrease and having an adverse effect on our business, financial condition
and results of operations, including our ability to attract and retain qualified employees and to raise capital. </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B><B><I>It is not possible to predict the actual
number of shares of Common Stock we will issue upon conversion of the Notes.</I></B></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Selling Stockholders have the option to determine
whether the obligations outstanding under the Notes are paid in cash or shares of Common Stock. Accordingly, the actual number of shares
of Common Stock that will be issued upon conversion of the Notes, if any, cannot be determined at this time.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>The sale of a substantial amount of our
shares in the public market could adversely affect the prevailing market price of our securities.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> We are registering for resale up to 2,290,312 shares of our Common
Stock, which is a significant number of shares compared to the current number of shares of our Common Stock issued and outstanding. Sales
of a substantial amount of shares of our Common Stock in the public market, or the perception that such sales might occur, could adversely
affect the market price of our Common Stock. The issuance of the Conversion Shares and the First Warrant Shares, for example, is likely
to further depress the price of our Common Stock, which could, among other factors, make it more difficult for us to maintain compliance
with Nasdaq&rsquo;s continued listing requirements. We cannot predict if and when the Selling Stockholders may sell such shares of our
Common Stock in the public markets. Furthermore, in the future, we may issue additional shares of our Common Stock or other equity or
debt securities convertible into shares of our Common Stock. Any such issuance could result in substantial dilution to our existing stockholders
and could cause the market price of our securities to decline. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>The issuance of the shares of Common Stock
covered by this prospectus could significantly increase the total number of shares of Common Stock issued and outstanding and thereby
cause our existing stockholders to experience substantial dilution.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> The shares of Common Stock being offered pursuant to this prospectus
represent Conversion Shares and First Warrant Shares. As of April 8, 2026, there were 2,507,537 shares of Common Stock issued and outstanding
(prior to any deemed issuance of any Conversion Shares or First Warrant Shares). The number of shares covered by this prospectus represents
approximately 91% of the number of shares of Common Stock issued and outstanding as of the date of this prospectus. As a result, if we
are required to issue the maximum number of Private Placement Shares that are being registered hereunder, an existing stockholder&rsquo;s
proportionate interest in us will be substantially diluted. The actual number of shares of Common Stock that we issue to the Selling Stockholders
may be less than the aggregate number of shares covered by this prospectus. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Under the Purchase Agreement, we are subject
to certain restrictive covenants that may make it difficult to procure additional financing.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> The Purchase Agreement contains restrictive
covenants which restrict our ability to issue securities or file additional registration statements. If we require additional funding
while these restrictive covenants remain in effect, we may be unable to effect a financing transaction on terms acceptable to us, or
at all, while also remaining in compliance with the terms of the Purchase Agreement, or we may be forced to seek a waiver from the purchasers
party to the Purchase Agreement, which such purchasers are not obligated to grant to us. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B><I>Investors who buy
shares at different times will likely pay different prices.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Investors who purchase
Private Placement Shares in this offering at different times will likely pay different prices, and so may experience different levels
of dilution and different outcomes in their investment results. The Selling Stockholders may sell such Private Placement Shares at different
times and at different prices.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>We have additional securities available
for issuance, which, if issued, could adversely affect the rights of the holders of our Common Stock.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We may from time-to-time issue additional shares
of Common Stock or preferred stock. In addition, as opportunities present themselves, we may enter into financing or similar arrangements
in the future, including the issuance of debt securities, Common Stock or preferred stock. Any future issuances of Common Stock or securities
convertible into Common Stock, would further dilute the percentage ownership of us held by holders of Common Stock. In addition, the issuance
of certain securities, may be used as an &ldquo;anti-takeover&rdquo; device without further action on the part of our stockholders, and
may adversely affect the holders of the Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <B><I>Stockholders may experience significant
dilution as a result of potential future financings.</I></B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Purchasers of the Private Placement Shares in
this offering, as well as our existing stockholders, will experience significant dilution if we sell additional shares at prices significantly
below the price at which they invested. In addition, we may issue additional shares of Common Stock or other equity securities exercisable
for shares of Common Stock in connection with, among other things, future acquisitions of additional companies or assets, or under our
equity incentive plans, in certain cases without stockholder approval. Our existing stockholders may experience significant dilution if
we issue shares of Common Stock in the future at prices below the price at which previous stockholders invested.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our issuance of additional shares of Common Stock
or other Common Stock equivalents would have the following effects:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">our existing stockholders&rsquo; proportionate ownership interest in us will decrease;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the relative voting strength of each previously outstanding ordinary share may be diminished; and</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the market price of our Common Stocks may decline.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>An active trading market for our Common
Stock may not be sustained.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Although our Common Stock is listed on Nasdaq,
the market for our Common Stock has demonstrated varying levels of trading activity. Furthermore, the current level of trading may not
be sustained in the future. The lack of an active market for our Common Stock may impair investors&rsquo; ability to sell their shares
of Common Stock at the time they wish to sell them or at a price that they consider reasonable, may reduce the fair market value of their
shares of Common Stock and may impair our ability to raise capital to continue to fund operations by selling shares and may impair our
ability to utilize our shares as consideration in any licensing or other collaboration transactions with third parties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Our share price may be subject to substantial
volatility, and stockholders may lose all or a substantial part of their investment.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Common Stock is currently traded on Nasdaq.
There is limited public float, and trading volume historically has been low and sporadic. As a result, the market price for our Common
Stock may not necessarily be a reliable indicator of our fair market value. The price at which our Common Stock trades may fluctuate as
a result of a number of factors, including the number of shares available for sale in the market, quarterly variations in our operating
results, actual or anticipated announcements of new releases by us or competitors, the gain or loss of sources of revenues, changes in
the estimates of our operating performance, market conditions in our industry and the economy as a whole.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><A NAME="ren_005"></A><B>SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> This prospectus and the documents incorporated
by reference into this prospectus include forward-looking&nbsp;statements within the meaning of Section&nbsp;27A of the Securities Act,
and Section&nbsp;21E of the Securities Exchange&nbsp;Act&nbsp;of&nbsp;1934, as amended, or the Exchange&nbsp;Act, that relate to future
events or our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our actual
results, levels of activity, performance or achievements to differ materially from any future results, levels of activity, performance
or achievements expressed or implied by these forward-looking&nbsp;statements. Words such as, but not limited to, &ldquo;anticipate,&rdquo;
&ldquo;aim,&rdquo; &ldquo;believe,&rdquo; &ldquo;contemplate,&rdquo; &ldquo;continue,&rdquo; &ldquo;could,&rdquo; &ldquo;design,&rdquo;
&ldquo;estimate,&rdquo; &ldquo;expect,&rdquo; &ldquo;intend,&rdquo; &ldquo;may,&rdquo; &ldquo;might,&rdquo; &ldquo;plan,&rdquo; &ldquo;predict,&rdquo;
&ldquo;poise,&rdquo; &ldquo;project,&rdquo; &ldquo;potential,&rdquo; &ldquo;suggest,&rdquo; &ldquo;should,&rdquo; &ldquo;strategy,&rdquo;
&ldquo;target,&rdquo; &ldquo;will,&rdquo; &ldquo;would,&rdquo; and similar expressions or phrases, or the negative of those expressions
or phrases, are intended to identify forward-looking&nbsp;statements, although not all forward-looking&nbsp;statements contain these
identifying words. Although we believe that we have a reasonable basis for each forward-looking&nbsp;statement contained in this prospectus
and incorporated by reference into this prospectus, we caution you that these statements are based on our projections of the future that
are subject to known and unknown risks and uncertainties and other factors that may cause our actual results, level of activity, performance
or achievements expressed or implied by these forward-looking&nbsp;statements, to differ. The section in this prospectus entitled &ldquo;<I>Risk
Factors</I>&rdquo; and the sections in our periodic reports, including the Annual Report on Form&nbsp;10-K&nbsp;for the year ended December&nbsp;31,
2025 filed with the SEC, on April 1, 2026 entitled &ldquo;Business,&rdquo; &ldquo;Risk Factors&rdquo; and &ldquo;Management&rsquo;s Discussion
and Analysis of Financial Condition and Results of Operations,&rdquo; as well as other sections in this prospectus and the documents
or reports incorporated by reference into this prospectus, discuss some of the factors that could contribute to these differences. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Please consider our forward-looking&nbsp;statements
in light of those risks as you read this prospectus and the documents incorporated by reference into this prospectus. It is not possible
for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor,
or combination of factors, may cause actual results to differ materially from those contained in any forward-looking&nbsp;statements we
may make. Given these uncertainties, you should not place undue reliance on these forward-looking&nbsp;statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You should not assume that the information contained
in this prospectus is accurate as of any date other than as of the date of this prospectus, or that any information incorporated by reference
into this prospectus is accurate as of any date other than the date of the document so incorporated by reference. Except as required by
law, we assume no obligation to update these forward-looking&nbsp;statements publicly, or to update the reasons actual results could differ
materially from those anticipated in these forward-looking&nbsp;statements, even if new information becomes available in the future. Thus,
you should not assume that our silence over time means that actual events are bearing out as expressed or implied in such forward-looking&nbsp;statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If one or more of these or other risks or uncertainties
materializes, or if our underlying assumptions prove to be incorrect, actual results may vary materially from what we anticipate. All
subsequent written and oral forward-looking&nbsp;statements attributable to us or individuals acting on our behalf are expressly qualified
in their entirety by this Note. Before purchasing any securities, you should consider carefully all of the factors set forth or referred
to in this prospectus and the documents incorporated by reference that could cause actual results to differ.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We may not actually achieve the plans, intentions
or expectations disclosed in our forward-looking&nbsp;statements, and you should not place undue reliance on our forward-looking&nbsp;statements.
Forward-looking&nbsp;statements should be regarded solely as our current plans, estimates and beliefs. We have included important factors
in the cautionary statements included in this document, particularly in the section entitled &ldquo;<I>Risk Factors</I>&rdquo; of this
prospectus that we believe could cause actual results or events to differ materially from the forward-looking&nbsp;statements that we
make. Moreover, we operate in a very competitive and rapidly changing environment. New risks emerge from time to time. It is not possible
for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor,
or combination of factors, may cause actual results to differ materially from those contained in any forward-looking&nbsp;statements we
may make. Given these risks and uncertainties, readers are cautioned not to place undue reliance on such forward-looking&nbsp;statements.
All forward-looking&nbsp;statements are qualified in their entirety by this cautionary statement. Our forward-looking&nbsp;statements
do not reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures or investments we may make. You
should read this prospectus and the documents that we have filed as exhibits to this prospectus and incorporated by reference herein completely
and with the understanding that our actual future results may be materially different from the plans, intentions and expectations disclosed
in the forward-looking&nbsp;statements we make. The forward-looking&nbsp;statements contained in this prospectus are made as of the date
of this prospectus and we do not assume any obligation to update any forward-looking&nbsp;statements, whether as a result of new information,
future events or otherwise, except as required by applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><A NAME="ren_006"></A><B>THE PRIVATE PLACEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> On February 12, 2026, we entered into a securities
purchase agreement&nbsp;<FONT STYLE="background-color: white">(the &ldquo;Purchase Agreement&rdquo;)</FONT>&nbsp;with the Selling Stockholders
for the issuance and sale in a private placement (the &ldquo;Private Placement&rdquo;) of Notes in the aggregate principal amount of
$6,042,985.39. The Notes bear interest at a rate of 12% per annum, will mature 13 months from the date of issuance, subject to limited
extension and, without taking into account any accrued and unpaid interest, are initially convertible, at the option of the holder, into
an aggregate of 1,075,264 shares of Common Stock, at a conversion price of $5.62 per share (the &ldquo;Conversion Price&rdquo;). In connection
with the Private Placement, the Company also issued to the Selling Stockholders warrants (collectively, the &ldquo;Warrants&rdquo;)&nbsp;
to purchase an aggregate of 1,937,598 shares of Common Stock (which is equal to the face value of the Notes divided by the exercise price
of the Warrants), consisting of (i) First Warrants to purchase 1,075,264 shares of Common Stock, which are exercisable immediately upon
issuance, and (ii) additional warrants (the &ldquo;Second Warrants&rdquo;) to purchase 862,335 shares of Common Stock, which cannot be
exercised by the Selling Stockholders unless and until Stockholder Approval (as defined below) is obtained. The First Warrants have a
term of six years from the date of issuance and are exercisable at a price of $3.1188 per share of Common Stock, and the Second Warrants
will have a term of six years from the date that Stockholder Approval is obtained and will be exercisable at a price of $3.1188 per share
of Common Stock. The shares of Common Stock issuable upon exercise of the Second Warrants (the &ldquo;Second Warrant Shares&rdquo;) are
not being registered for resale in this Offering. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> The Private Placement closed on February 17,
2026 (the &ldquo;Closing Date&rdquo;).&nbsp;The net proceeds to the Company from the Private Placement were approximately $5.4 million,
after deducting placement agent fees and the payment of other offering expenses associated with the offering that were payable by the
Company and excluding any deductions for make whole payments made to certain of the investors. The Company intends to use the net proceeds
from the Private Placement for working capital purposes. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> Dawson James Securities, Inc. (&ldquo;Dawson
James&rdquo;) served as the exclusive placement agent in connection with the Private Placement and was paid (i)&nbsp;a cash fee equal
to 7.0% of the aggregate gross proceeds of the Private Placement, and (ii) $50,000 for legal fees and other out-of-pocket expenses. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Set forth below is a summary of the Private Placement
transaction and the related agreements. Copies of the related agreements have been filed as exhibits to this registration statement and
our Current Report on Form 8-K, filed with the SEC on February 17, 2026. You are encouraged to review the full text of such agreements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>The Securities Purchase Agreement</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> The Purchase Agreement contains restrictive
covenants which restrict our ability to issue securities or file additional registration statements. The Purchase Agreement further provides
that until the date on which the Notes are no longer outstanding, the Company will be prohibited from effecting or entering into an agreement
to effect any issuance by the Company or any of its subsidiaries of Common Stock or common stock equivalents (or a combination of units
thereof) involving a Variable Rate Transaction (as defined therein). </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> Pursuant to the Purchase Agreement, until
12 months after the date on which the Notes are no longer outstanding, upon the Company or any of its subsidiaries issuing any securities,
including Common Stock, preferred stock, Indebtedness (as defined in the Purchase Agreement) or options or securities convertible into
shares of Common Stock (a &ldquo;Subsequent Financing&rdquo;), the Selling Stockholders shall have the right to participate in the Subsequent
Financing up to an amount, in the aggregate, equal to 50% of the Subsequent Financing on the same terms, conditions and price provided
for in the financing. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> The Purchase Agreement contains customary
representations, warranties, agreements and conditions to completing future sale transactions, indemnification rights and obligations
of the parties. Among other things, each of the Selling Stockholders represented to the Company, that it is an &ldquo;accredited investor&rdquo;
(as such term is defined in Rule 501(a) of Regulation D under the Securities Act), and the Company sold the securities in reliance upon
an exemption from registration contained in Section 4(a)(2) of the Securities Act and/or Regulation D promulgated thereunder. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Securities Issued</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The Senior Convertible Notes</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Notes mature 13 months from their date of
issuance (subject to extension under certain circumstances), bear interest at a rate of 12% per annum, and are payable in ten monthly
installments in an amount equal to 110% of (i) 1/10<SUP>th</SUP> of the principal of the Notes (ii) plus accrued interest, with the first
installment due and payable on the earlier of 180 days from the Closing Date or 90 days following the date that this registration statement
is declared effective by the SEC. The Notes are unsecured and are senior to all other Indebtedness (as such term is defined in the Notes)
of the Company and its subsidiaries, with each Note ranking <I>pari passu</I> with all other Notes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> The Notes are convertible, at the option of
the holder, at any time after the date of issuance, into that number of shares of Common Stock equal to the principal amount of the Notes,
plus all accrued and unpaid interest and late charges and any other unpaid amounts, at the Conversion Price of $5.62 per share, subject
to adjustment for any stock splits, stock dividends, recapitalizations and similar events. The holders of the Notes are prohibited from
converting the Notes into shares of Common Stock if, as a result of such conversion, such holder, together with its affiliates, would
beneficially own in excess of 4.99% (or, at the option of the holder, 9.99%) of the total number of shares of Common Stock issued and
outstanding immediately after giving effect to such exercise. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Notes are redeemable by the Company at any
time, at the Company&rsquo;s option, in whole or in part, at a redemption price equal to 110% of the sum of the principal amount to be
redeemed plus accrued interest, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Notes contain customary events of default.
If an event of default occurs, from and after the occurrence, and during the continuance of, an such event of default, the interest rate
of the Notes shall automatically increase to 18% per annum until such event of default is cured. Additionally, if an event of default
occurs, the holders of outstanding Notes may, regardless of whether such event of default has been cured, require the Company to redeem
all or any portion of the outstanding Notes at a price equal to the greater of (i) the product of (A) the value of the Notes to be redeemed
multiplied by (B) 110% and (ii) the product of (X) the value of the Notes to be redeemed, divided by the Conversion Price (the &ldquo;Conversion
Rate&rdquo;), multiplied by (Y) the product of (1) 110% multiplied by (2) the greatest closing sale price of the Common Stock on any trading
day during the period commencing on the date immediately preceding such event of default and ending on the date the Company makes the
entire payment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the Notes, the Company shall not enter
into or be a party to a Fundamental Transaction (as such term is defined in the Notes) unless (i) the successor entity assumes in writing
all of the obligations under the Notes and the other transaction documents and (ii) the successor entity is a publicly traded corporation
whose common stock is quoted on or listed for trading on an eligible market, as set forth in the Notes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">While the Notes are outstanding, subject to certain
exempt issuances, if the Company sells, offers or grants any option or right to purchase, or otherwise disposes of or sells any equity
security or equity-linked or related security, any convertible securities any preferred stock or other securities, the holders of outstanding
Notes shall have the right, in their sole discretion, to require that the Company apply up to 30% of the gross proceeds from such sales
or offers to redeem all, or any portion, of the outstanding Notes at a price equal to 110% of the amount of the Note being redeemed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> Without giving effect to any default interest or penalties which may
accrue thereunder, assuming the full conversion of the Notes plus accrued interest in full into Common Stock without regard to any conversion
limitations set forth in the Notes (assuming the Notes accrued interest at 12% for a period of thirteen (13) months), approximately 1,215,048
shares of Common Stock would be issuable upon conversion, all of which shares are being registered pursuant to this registration statement.

<B>&nbsp;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&nbsp;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>The Warrants</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Stockholder Approval</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> Pursuant to the Second Warrants, we agreed
to file a proxy statement with the SEC within 45 days of the Closing Date (which 45 days has been extended by an additional 28 days)
and hold a meeting of stockholders at the earliest practical date after the date following the filing thereof (and in no event later
than 90 days after the Closing Date, which 90 days has been extended by an additional 28 days) (the &ldquo;Stockholder Meeting Deadline&rdquo;)
for the purpose of obtaining such approval as may be required under the applicable rules of Nasdaq from our stockholders with respect
to the issuance of all of the Second Warrant Shares upon the exercise of the Second Warrants in accordance with their terms (including
adjustment provisions set forth therein) (the &ldquo;Stockholder Approval&rdquo;). </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We agreed to use our reasonable best efforts to
obtain such Stockholder Approval. If, despite our reasonable best efforts the Stockholder Approval is not obtained on or prior to the
Stockholder Meeting Deadline, we are obligated to cause an additional stockholder meeting to be held on or prior to the 90th calendar
day following the failure to obtain Stockholder Approval. If, despite the Company&rsquo;s reasonable best efforts the Stockholder Approval
is not obtained after such subsequent stockholder meetings, the Company shall cause an additional Stockholder Meeting to be held every
90 days thereafter until such Stockholder Approval is obtained, or the Second Warrants are no longer outstanding, whichever is sooner.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Exercise Price</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> The First Warrants are immediately exercisable
upon issuance, have a term of six years from the date of issuance, and are exercisable for shares of Common Stock at a price of $3.1188
per share. The Second Warrants shall become exercisable on such date, if ever, that Stockholder Approval is obtained, have a term of
six years from the date of Stockholder Approval, and will be exercisable for shares of Common Stock at a price of $3.1188 per share. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The exercise price and number of shares of Common
Stock issuable upon exercise of the Warrants are subject to customary adjustments pursuant to stock dividends, stock splits or similar
events.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Cashless Exercise</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> In the event there is no effective registration
statement registering, or the prospectus contained therein is not available for the resale of the shares of Common Stock issuable upon
exercise of the Warrants (the &ldquo;Warrant Shares&rdquo;), the Warrants may be exercised, in whole or in part, by means of a &ldquo;cashless
exercise&rdquo; in which case the holder will be entitled to receive a number of Warrant Shares equal to the quotient obtained by dividing,
(x) (A) as applicable, the volume weighted average price (&ldquo;VWAP&rdquo;) of the Common Stock on the date immediately preceding the
exercise date (if the notice of exercise is (1) both executed and delivered on a day that is not a Trading Day (as defined in the Warrant)
or (2) both executed and delivered on a Trading Day prior to the opening of &ldquo;regular trading hours) or the bid price of the Common
Stock as of the time of the holder&rsquo;s execution of the applicable notice of exercise (if the notice of exercise is executed during
&ldquo;regular trading hours&rdquo; on a Trading Day), less the exercise price of the Warrant, multiplied by (B) the number of Warrant
Shares that would be issuable upon exercise of the Warrant if the exercise were by means of a cash exercise rather than a cashless exercise,
by (y) the price used in (A).&nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I></I>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Fundamental Transaction</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If a Fundamental Transaction (as such term is
defined in the Warrants) occurs, then the successor entity will succeed to, and be substituted for the Company, and may exercise every
right and power that the Company may exercise and will assume all of the Company&rsquo;s obligations under the Warrants with the same
effect as if such successor entity had been named in the Warrant itself. If holders of the Common Stock are given a choice as to the securities,
cash or property to be received in a fundamental transaction, then the holder shall be given the same choice as to the consideration it
receives upon any exercise of the Warrant following such Fundamental Transaction. In certain circumstances, the holder will have the right
to receive the Black Scholes Value of the Warrant calculated pursuant to a formula set forth in the Warrants, payable either in cash or
in the same type or form of consideration that is being offered and being paid to the holders of the Common Stock as described in the
Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Rights of Holder</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Except as otherwise provided in the Warrants or
by virtue of such holder&rsquo;s ownership of shares of Common Stock, the holder of a Warrant does not have the rights or privileges of
a holder of the Common Stock, including any voting rights, until the holder exercises the Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Limitations on Exercise</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The holders of the Warrants are prohibited from
exercising the Warrants for shares of Common Stock if, as a result of such conversion, such holder, together with its affiliates, would
beneficially own in excess of 4.99% (or, at the option of the holder, 9.99%) of the total number of shares of Common Stock issued and
outstanding immediately after giving effect to such exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>The Registration Rights Agreement</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> In connection with the Private Placement,
the Company entered into a registration rights agreement (the &ldquo;Registration Rights Agreement&rdquo;), dated February 12, 2026,
with the Selling Stockholders, pursuant to which the Company agreed to prepare and file a registration statement with the SEC registering
the resale of: (a) all Warrant Shares then issued and issuable upon exercise of the Warrants (assuming on such date the Warrants are
exercised in full without regard to any exercise limitations therein), (b) all Conversion Shares then issued and issuable upon conversion
of the Notes (assuming on such date the Notes are converted in full without regard to any conversion limitations therein), (c) any additional
shares of Common Stock issued and issuable in connection with any anti-dilution provisions in the Warrants and/or the Notes, as applicable
(without giving effect to any limitations on exercise set forth in the Warrants and/or the Notes, as applicable) and (d) any securities
issued or then issuable upon any stock split, dividend or other distribution, recapitalization or similar event with respect to the foregoing
(collectively, the &ldquo;Registrable Securities&rdquo;) no later than 30 calendar days after the Closing Date (the &ldquo;Filing Date&rdquo;)
and to use its commercially reasonable efforts to have the registration statement declared effective as promptly as possible thereafter,
and in any event not more than 45 days following the Closing Date, which 45 days has been extended by an additional 12 days (or 75 days
following the Closing Date in the event of a &ldquo;full review&rdquo; by the SEC) (the &ldquo;Effectiveness Date&rdquo;). If certain
of the Company's obligations under the&nbsp;Registration&nbsp;Rights&nbsp;Agreement&nbsp;are not met, the Company is required to pay
the Selling Stockholders&nbsp;liquidated&nbsp;damages. The Registration Rights Agreement further provides that the Company shall use
commercially reasonable efforts to keep such registration statement effective at all times until all Registrable Securities covered by
such registration statement have been sold or may be sold without volume or manner-of-sale restrictions pursuant to Rule&nbsp;144 and
without the requirement for the Company to be in compliance with the current public information requirement under Rule&nbsp;144. This
Registration Statement does not register the resale of the Second Warrant Shares. We will be obligated to file another registration statement
to register the Second Warrant Shares within ten days of obtaining Stockholder Approval. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>The Placement Agency Agreement</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dawson James served as the Company&rsquo;s exclusive
placement agent in connection with the Private Placement pursuant to the terms of a placement agency agreement (the &ldquo;Placement Agency
Agreement&rdquo;), dated February 12, 2026, entered into between the Company and Dawson James. Pursuant to the Placement Agency Agreement,
Dawson James is entitled to receive (i)&nbsp;a cash fee equal to 7.0% of the aggregate gross proceeds of the Private Placement, and (ii)&nbsp;up
to $50,000 for legal fees and other out-of-pocket expenses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the Placement Agency Agreement, the
directors, officers and 5% stockholders of the Company executed lock-up agreements, pursuant to which they agreed not to offer, pledge,
sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant
to purchase, lend, or otherwise transfer or dispose of, directly or indirectly, any shares of capital stock of the Company or any securities
convertible into or exercisable or exchangeable for shares of capital stock of the Company until 30 days after the effective date of the
Initial Registration Statement (as such term is defined in the Registration Rights Agreement).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><A NAME="ren_007"></A><B>USE OF PROCEEDS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> We will not receive any proceeds from the
sale of the Private Placement Shares by the Selling Stockholders. We will, however, receive up to an aggregate of approximately $3.5
million in cash from the exercise of the First Warrants, assuming the exercise in full for cash of all the First Warrants, which we intend
to use for working capital and general corporate purposes. &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Selling Stockholders will receive all of the
proceeds of the sale of Private Placement Shares offered from time to time pursuant to this prospectus. Accordingly, we will not receive
any proceeds from the sale of the Private Placement Shares that may be sold from time to time pursuant to this prospectus. See &ldquo;Plan
of Distribution&rdquo; elsewhere in this prospectus for more information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="ren_008"></A>SELLING STOCKHOLDERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> The Private Placement Shares being offered by the Selling Stockholders
are those issuable to the Selling Stockholders upon conversion of the Notes and exercise of the First Warrants. Included in the Private
Placement Shares being offered by the Selling Stockholders are: 1,215,048 shares of Common Stock issuable upon the conversion of the Notes,
assuming the conversion of the full $6,042,985.39 in principal plus interest of $785,588 (assuming the Notes accrued interest at 12% for
a period of thirteen (13) months); and (ii) 1,075,264 First Warrant Shares issuable upon exercise of First Warrants. The Private Placement
Shares being offered by the Selling Stockholders do not include 862,335 Second Warrant Shares issuable upon exercise of Second Warrants,
subject to receipt of Stockholder Approval. For additional information regarding the issuances of the Notes and the Warrants, see &ldquo;The
Private Placement,&rdquo; above. We are registering the Private Placement Shares in order to permit the Selling Stockholders to offer
the Private Placement Shares for resale from time to time. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> Each of the Selling Stockholders entered into
a securities purchase agreement with the Company on October 16, 2025, pursuant to which they purchased shares of Series B Convertible
Preferred Stock (&ldquo;Series B Preferred Stock&rdquo;) and warrants from the Company, at a combined purchase price of $25.00 for each
shares of Series B Preferred Stock and accompanying warrant, in a private placement transaction, which closed on October 17, 2025. As
of February 17, 2026, all shares of Series B Preferred Stock and warrants purchased by the Selling Stockholders in such offering had
been converted and exercised, as applicable, and are no longer outstanding. Except for the foregoing and the ownership of the Notes and
the Warrants, the Selling Stockholders have not had any material relationship with us within the past three years. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> The table below lists the Selling Stockholders and other information
regarding the beneficial ownership of the shares of Common Stock by each of the Selling Stockholders. The second column lists the number
of shares of Common Stock beneficially owned by each Selling Stockholder, based on its ownership of shares of Common Stock, the Notes,
the First Warrants and other outstanding securities convertible or exercisable for shares of Common Stock, as of April 8, 2026, assuming
conversion and exercise of the Notes, First Warrants and other outstanding securities convertible or exercisable for shares of Common
Stock, as applicable, held by the Selling Stockholders on that date, without regard to any limitations on exercises or conversions. The
second column does not include the shares of Common Stock issuable upon exercise of the Second Warrants, the exercise of which is subject
to receipt of Stockholder Approval. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> The third column lists the shares of Common
Stock being offered by this prospectus by the Selling Stockholders.&nbsp;In accordance with the terms of a registration rights agreement
entered into with the Selling Stockholders, this prospectus generally covers the resale of the maximum number of shares of Common Stock
issuable upon conversion or exercise of the Notes and the First Warrants, as applicable, determined as if the outstanding Notes and First
Warrants were converted or exercised in full, as applicable, as of the trading day immediately preceding the date this registration statement
was initially filed with the SEC, each as of the trading day immediately preceding the applicable date of determination and all subject
to adjustment as provided in the registration right agreement, without regard to any limitations on exercises or conversions. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The fourth column assumes the sale of all of the
shares of Common Stock offered by the Selling Stockholders pursuant to this prospectus. Because each Selling Stockholder may dispose of
all, none or some portion of their Private Placement Shares, no estimate can be given as to the number of Private Placement Shares that
will be beneficially owned by a Selling Stockholder upon termination of this offering. For purposes of the table below, however, we have
assumed that after termination of this offering none of the Private Placement Shares covered by this prospectus will be beneficially owned
by the Selling Stockholders and further assumed that the Selling Stockholders will not acquire beneficial ownership of any additional
shares of our Common Stock during the offering. In addition, the Selling Stockholders may have sold, transferred or otherwise disposed
of, or may sell, transfer or otherwise dispose of, at any time and from time to time, the Private Placement Shares in transactions exempt
from the registration requirements of the Securities Act after the date on which the information in the table is presented.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> Under the terms of the Notes and the First
Warrants, a Selling Stockholder may not convert or exercise its applicable Notes or First Warrants to the extent such exercise or conversion,
as applicable, would cause such Selling Stockholder, together with its affiliates and attribution parties, to beneficially own a number
of shares of Common Stock which would exceed 4.99% (or, at the election of the holder, 9.99%) of our then outstanding Common Stock following
such exercise or conversion, as applicable, excluding for purposes of such determination shares of Common Stock issuable upon conversion
of the Notes or exercise of the First Warrants which have not been converted or exercised. The number of shares in the second and fourth
columns does not reflect this limitation. The Selling Stockholders may sell all, some or none of their shares in this offering. See &ldquo;Plan
of Distribution.&rdquo; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> Beneficial ownership is determined in accordance with Rule 13d-3(d)
promulgated by the SEC under the Exchange Act, and includes our shares of Common Stock with respect to which the Selling Stockholders
have sole or shared voting and investment power. The percentage of our shares of Common Stock beneficially owned by the Selling Stockholders
prior to the offering shown in the table below is based on 2,507,537 shares of our Common Stock outstanding on April 8, 2026. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Shares
    of Common</B></FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Maximum
    Number</B></FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD COLSPAN="5"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> <B>Shares of Common Stock</B> </P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> <B>To Be Beneficially Owned</B> </P></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Stock</B></FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>of Private</B></FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD COLSPAN="5" STYLE="text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Immediately
    Following</B></FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Beneficially</B></FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Placement</B></FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD COLSPAN="5" STYLE="text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>the Sale
    of the Private</B></FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Owned</B></FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Shares</B></FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD COLSPAN="5" STYLE="text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Placement
    Shares</B></FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Prior&nbsp;to
    the</B></FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Being&nbsp;Offered</B></FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD COLSPAN="5" STYLE="border-bottom: black 1.5pt solid; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Offered
    for Resale</B></FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name
    of Selling Stockholder</B></FONT> </TD>
    <TD> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Offering</B></FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>for
    Resale</B></FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number</B></FONT> </TD>
    <TD> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Percentage</B></FONT> </TD>
    <TD STYLE="border-bottom: black 1.5pt solid"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="text-align: right"> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="text-align: center"> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: center"> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="text-align: center"> &nbsp; </TD>
    <TD> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="width: 52%; padding-left: 9pt; text-indent: -9pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alto
    Opportunity Master Fund, SPC &ndash; Segregated Master Portfolio B<SUP>(1)</SUP></FONT> </TD>
    <TD STYLE="width: 1%"> &nbsp; </TD>
    <TD STYLE="width: 1%"> &nbsp; </TD>
    <TD STYLE="width: 9%; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">359,599</FONT> </TD>
    <TD STYLE="width: 1%"> &nbsp; </TD>
    <TD STYLE="width: 1%"> &nbsp; </TD>
    <TD STYLE="width: 1%"> &nbsp; </TD>
    <TD STYLE="width: 9%; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">357,394</FONT> </TD>
    <TD STYLE="width: 1%"> &nbsp; </TD>
    <TD STYLE="width: 1%"> &nbsp; </TD>
    <TD STYLE="width: 11%; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,205</FONT> </TD>
    <TD STYLE="width: 1%"> &nbsp; </TD>
    <TD STYLE="width: 1%"> &nbsp; </TD>
    <TD STYLE="width: 9%; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT> </TD>
    <TD STYLE="width: 1%"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="padding-left: 9pt; text-indent: -9pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Anson
    Investments Master Fund LP<SUP>(2)</SUP></FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,449,689</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,449,689</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT> </TD>
    <TD> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="padding-left: 9pt; text-indent: -9pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Anson
    East Master Fund LP<SUP>(3)</SUP></FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">483,229</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">483,229</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT> </TD>
    <TD> &nbsp; </TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">*</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Represents less than one percent (1%) of the outstanding Common Stock</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD> <FONT STYLE="font-size: 10pt">(1)</FONT> </TD>
    <TD>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> Shares of Common Stock beneficially owned
prior to the Offering include (i) 50 shares of Common Stock; (ii) 2,048 shares of Common Stock issuable upon conversion of 551 shares
of Series B Preferred Stock; (iii) 107 shares of Common Stock issuable upon conversion of warrants held prior to the Offering; (iv) 189,603
shares of Common Stock issuable upon conversion of a Note in the principal amount of $942,985.39, plus interest of $122,588 (assuming
the Note accrued interest at 12% for a period of thirteen (13) months); and (v) 167,791 First Warrant Shares issuable upon exercise of
First Warrants. The Shares of Common Stock beneficially owned prior to the Offering, do not include 134,564 Second Warrant Shares issuable
upon exercise of Second Warrants, subject to receipt of Stockholder Approval. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"> &nbsp; </P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"> Waqas Khatri has shared voting control and investment discretion
over the securities reported herein that are held by Alto Opportunity Master Fund, SPC. As a result, Mr. Khatri may be deemed to have
beneficial ownership of the securities reported herein that are held by Alto Opportunity Master Fund, SPC. Ayrton Capital LLC, the investment
manager to Alto Opportunity Master Fund, SPC - Segregated Master Portfolio B, has discretionary authority to vote and dispose of the
shares held by Alto Opportunity Master Fund, SPC - Segregated Master Portfolio B and may be deemed to be the beneficial owner of these
shares. Waqas Khatri, in his capacity as Managing Member of Ayrton Capital LLC, may also be deemed to have investment discretion and
voting power over the shares held by Alto Opportunity Master Fund, SPC - Segregated Master Portfolio B. Ayrton Capital LLC and Mr. Khatri
each disclaim any beneficial ownership of these shares. The address of Alto Opportunity Master Fund, SPC is c/o Ayrton LLC 55 Post Road,
W, 2<SUP>nd</SUP>&nbsp;Floor, Westport, Connecticut 06880. </P>

</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"> <FONT STYLE="font-size: 10pt">(2)</FONT> </TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> Shares of Common Stock beneficially
owned prior to the Offering include (i) 769,084 shares of Common Stock issuable upon conversion of a Note in the principal amount of
$3,825,000, plus interest of $497,250 (assuming the Note accrued interest at 12% for a period of thirteen (13) months); and (ii) 680,605
First Warrant Shares issuable upon exercise of First Warrants. Shares of Common Stock beneficially owned prior to the Offering do not
include 545,829 Second Warrant Shares issuable upon exercise of Second Warrants, subject to receipt of Stockholder Approval. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"> &nbsp; </P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"> Anson Advisors Inc and Anson Funds Management LP, the Co-Investment
Advisers of Anson Investments Master Fund LP (&ldquo;Anson&rdquo;), hold voting and dispositive power over the Common Shares held by
Anson. Tony Moore is the managing member of Anson Management GP LLC, which is the general partner of Anson Funds Management LP. Moez
Kassam and Amin Nathoo are directors of Anson Advisors Inc. Mr. Moore, Mr. Kassam and Mr. Nathoo each disclaim beneficial ownership of
these Common Shares except to the extent of their pecuniary interest therein. The principal business address of Anson is Maples Corporate
Services Limited, PO Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman Islands. </P>

</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD> <FONT STYLE="font-size: 10pt">(3)</FONT> </TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> Shares of Common Stock beneficially owned
    prior to the Offering include (i) 256,361 shares of Common Stock issuable upon conversion of a Note in the principal amount of $1,275,000,
    plus interest of $165,750 (assuming the Note accrued interest at 12% for a period of thirteen (13) months); and (ii) 226,868 First
    Warrant Shares issuable upon exercise of First Warrants Shares of Common Stock beneficially owned prior to the Offering do not include
    181,942 Second Warrant Shares issuable upon exercise of Second Warrants, subject to receipt of Stockholder Approval. </P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> &nbsp; </P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Anson Advisors Inc and Anson Funds Management
    LP, the Co-Investment Advisers of Anson East Master Fund LP (&ldquo;Anson&rdquo;), hold voting and dispositive power over the Common
    Shares held by Anson. Tony Moore is the managing member of Anson Management GP LLC, which is the general partner of Anson Funds Management
    LP. Moez Kassam and Amin Nathoo are directors of Anson Advisors Inc. Mr. Moore, Mr. Kassam and Mr. Nathoo each disclaim beneficial
    ownership of these Common Shares except to the extent of their pecuniary interest therein. The principal business address of Anson
    is Maples Corporate Services Limited, PO Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman Islands.</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 8pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><A NAME="ren_009"></A>PLAN OF DISTRIBUTION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Each Selling Stockholder of the Private Placement
Shares and any of their pledgees, assignees and successors-in-interest may, from time to time, sell any or all of their shares of Common
Stock covered hereby on the principal trading market or any other stoc<FONT STYLE="font-family: Times New Roman, Times, Serif">k exchange,
market or trading facility on which the securities are traded or in private transactions. These sales may be at fixed or negotiated prices.
A Selling Stockholder may use any one or more of the following methods when selling securities:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ordinary brokerage transactions
    and transactions in which the broker-dealer solicits purchasers;</FONT></TD></TR>
  <TR STYLE="font-size: 8pt">
    <TD STYLE="font-size: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 8pt; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">block trades in which the
    broker-dealer will attempt to sell the securities as agent but may position and resell a portion of the block as principal to facilitate
    the transaction;</FONT></TD></TR>
  <TR STYLE="font: 8pt Times New Roman, Times, Serif">
    <TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">purchases by a broker-dealer
    as principal and resale by the broker-dealer for its account;</FONT></TD></TR>
  <TR STYLE="font: 8pt Times New Roman, Times, Serif">
    <TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an exchange distribution
    in accordance with the rules of the applicable exchange;</FONT></TD></TR>
  <TR STYLE="font: 8pt Times New Roman, Times, Serif">
    <TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">privately negotiated transactions;</FONT></TD></TR>
  <TR STYLE="font: 8pt Times New Roman, Times, Serif">
    <TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">settlement of short sales;</FONT></TD></TR>
  <TR STYLE="font: 8pt Times New Roman, Times, Serif">
    <TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in transactions through broker-dealers that agree with
    the Selling Stockholders to sell a specified number of such securities at a stipulated price per security;</FONT></TD></TR>
  <TR STYLE="font: 8pt Times New Roman, Times, Serif">
    <TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">through the writing or
    settlement of options or other hedging transactions, whether through an options exchange or otherwise;</FONT></TD></TR>
  <TR STYLE="font: 8pt Times New Roman, Times, Serif">
    <TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a combination of any such methods of sale; or</FONT></TD></TR>
  <TR STYLE="font: 8pt Times New Roman, Times, Serif">
    <TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any other method permitted
    pursuant to applicable law.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-style: normal; font-weight: normal">The
Selling Stockholders may also sell securities under Rule 144 or any other exemption from registration under the Securi</FONT><FONT STYLE="font-style: normal; font-weight: normal">ties
Act, if available, rather than under this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-style: normal; font-weight: normal">Broker-dealers
engaged by the Selling Stockholders may arrange for other brokers-dealers to participate in sales. Broker-dealers may receive commissions
or discounts from the Selling Stockholders (or, if any broker-dealer acts as agent for the purchaser of securities, from the purchaser)
in amounts to be negotiated, but, except as set forth in a supplement to this prospectus, in the case of an agency transaction not in
excess of a customary brokerage commission in compliance with FINRA Rule 2121; and in the case of a principal transaction a markup or
markdown in compliance with FINRA Rule 2121. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-style: normal; font-weight: normal">In
connection with the sale of the securities or interests therein, the Selling Stockholders may enter into hedging transactions with broker-dealers
or other financial institutions, which may in turn engage in short sales of the securities in the course of hedging the positions they
assume. The Selling Stockholders may also sell securities short and deliver these securities to close out their short positions, or loan
or pledge the securities to broker-dealers that in turn may sell these securities. The Selling Stockholders may also enter into option
or other transactions with broker-dealers or other financial institutions or create one or more derivative securities which require the
delivery to such broker-dealer or other financial institution of securities offered by this prospectus, which securities such broker-dealer
or other financial institution may resell pursuant to this prospectus (as supplemented or amended to reflect such transaction).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-style: normal; font-weight: normal">The
Selling Stockholders and any broker-dealers or agents that are involved in selling the securities may be deemed to be &ldquo;underwriters&rdquo;
within the meaning of the Securities Act in connection with such sales. In such event, any commissions received by such broker-dealers
or agents and any profit on the resale of the securities purchased by them may be deemed to be underwriting commissions or discounts
under the Securities Act. Each Selling Stockholder has informed the Company that it does not have any written or oral agreement or understanding,
directly or indirectly, with any person to distribute the securities. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-style: normal; font-weight: normal">The
Company is required to pay certain fees and expenses incurred by the Company incident to the registration of the securities. The Company
has agreed to indemnify the Selling Stockholders against certain losses, claims, damages and liabilities, including liabilities under
the Securities Act. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-style: normal; font-weight: normal">We
agreed to keep this prospectus effective until the earlier of (i) the date on which the securities may be resold by the Selling Stockholders
without registration and without regard to any volume or manner-of-sale limitations by reason of Rule 144, without the requirement for
the Company to be in compliance with the current public information under Rule 144 under the Securities Act or any other rule of similar
effect or (ii) all of the securities have been sold pursuant to this prospectus or Rule 144 under the Securities Act or any other rule
of similar effect. The resale securities will be sold only through registered or licensed brokers or dealers if required under applicable
state securities laws. In addition, in certain states, the resale securities covered hereby may not be sold unless they have been registered
or qualified for sale in the applicable state or an exemption from the registration or qualification requirement is available and is
complied with.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-style: normal; font-weight: normal">Under
applicable rules and regulations under the Exchange Act, any person engaged in the distribution of the resale securities may not simultaneously
engage in market making activities with respect to the common stock for the applicable restricted period, as defined in Regulation M,
prior to the commencement of the distribution. In addition, the Selling Stockholders will be subject to applicable provisions of the
Exchange Act and the rules and regulations thereunder, including Regulation M, which may limit the timing of purchases and sales of the
common stock by the Selling Stockholders or any other person. We will make copies of this prospectus available to the Selling Stockholders
and have informed them of the need to deliver a copy of this prospectus to each purchaser at or prior to the time of the sale (including
by compliance with Rule 172 under the Securities Act).</FONT></P>




<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><A NAME="ren_010"></A>LEGAL MATTERS</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The validity of the Private Placement Shares offered
hereby will be passed upon for us by Blank Rome LLP.</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><A NAME="ren_011"></A><B>EXPERTS</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>RenX Enterprises Corp.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> The consolidated financial statements of RenX
Enterprises Corp. (fka Safe and Green Development Corporation) and Subsidiaries for the two&nbsp;years ended December&nbsp;31, 2025 and
2024 have been audited by M&amp;K CPA&rsquo;s, PLLC, independent registered public accounting firm, as set forth in their report thereon
appearing in our Annual Report on Form&nbsp;10-K&nbsp;for the year ended December&nbsp;31, 2025, and incorporated by reference herein.
Such consolidated financial statements are incorporated by reference herein in reliance upon such report, which includes an explanatory
paragraph on our ability to continue as a going concern, given on the authority of such firm as experts in accounting and auditing. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <B>Resource Group US Holdings LLC</B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> The financial statements of Resource Group
US Holdings LLC for the two&nbsp;years ended December&nbsp;31, 2024 and 2023, have been audited by M&amp;K CPA&rsquo;s, PLLC, independent
registered public accounting firm, as set forth in their report thereon appearing in RenX Enterprises Corp.&rsquo;s Current Report on
Form 8-K filed on August 12, 2025, and incorporated by reference herein. Such consolidated financial statements are incorporated by reference
herein in reliance upon such report.&nbsp; </P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><A NAME="ren_012"></A><B>WHERE YOU CAN FIND MORE INFORMATION</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This prospectus is part of a registration statement
we filed with the SEC. This prospectus does not contain all of the information set forth in the registration statement and the exhibits
to the registration statement. For further information with respect to us and the securities being offered under this prospectus, we refer
you to the registration statement and the exhibits and schedules filed as a part of the registration statement. Neither we, the Selling
Stockholders nor any agent, underwriter or dealer has authorized any person to provide you with different information. Neither we nor
the Selling Stockholders are making an offer of these securities in any state where the offer is not permitted. You should not assume
that the information in this prospectus is accurate as of any date other than the date on the front page&nbsp;of this prospectus, regardless
of the time of delivery of this prospectus or any sale of the securities offered by this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We file annual, quarterly and current reports,
proxy statements and other information with the SEC. Our SEC filings are available to the public at the SEC&rsquo;s website at&nbsp;<I>www.sec.gov</I>.
Additional information about RenX Enterprises Corp. is contained at our website, <I>www.renxent.com</I>. Information on our website is
not incorporated by reference into this prospectus. We make available on our website our SEC filings as soon as reasonably practicable
after those reports are filed with the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="ren_013"></A>INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The SEC allows us to &ldquo;incorporate by reference&rdquo;
information from other documents that we file with it, which means that we can disclose important information to you by referring you
to those documents. The information incorporated by reference is considered to be part of this prospectus. Information in this prospectus
supersedes information incorporated by reference that we filed with the SEC prior to the date of this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We incorporate by reference into this prospectus
and the registration statement of which this prospectus is a part the information or documents listed below that we have filed with the
SEC (Commission File No. 001-41581):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"> &nbsp; </TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"> <FONT STYLE="font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="font-size: 10pt; text-align: justify"> Our Annual Report on&nbsp;<A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1959023/000121390026037999/ea0283352-10k_renx.htm">Form&nbsp;10-K</A>&nbsp;for the fiscal year ended December&nbsp;31,
    2025 filed with the SEC on April 1, 2026; </TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"> &nbsp; </TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"> <FONT STYLE="font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="font-size: 10pt; text-align: justify"> <FONT STYLE="font-size: 10pt">Our Current Reports on Form&nbsp;8-K, filed with
    the SEC on&nbsp; <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1959023/000121390025075095/ea0249114-8ka1_safe.htm">August 12, 2025</A>, <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1959023/000121390026001868/ea0272018-8k_renx.htm">January 6, 2026</A>, <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1959023/000121390026003507/ea0272589-8k_renx.htm">January 12, 2026</A>, <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1959023/000121390026010326/ea0274382-8k_renx.htm">January 30, 2026</A>, <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1959023/000121390026017314/ea0276978-8k_renx.htm">February 17, 2026</A> and <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1959023/000121390026035974/ea0283811-8k_renx.htm">March 30, 2026</A>; and</FONT> </TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in; font-size: 10pt"> &nbsp; </TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"> <FONT STYLE="font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"> The description
                                            of the Common Stock contained in the Registrant&rsquo;s Registration Statement on&nbsp;<A HREF="https://www.sec.gov/Archives/edgar/data/1959023/000121390022082588/ea170280-1012b_safeandgreen.htm">Form 10</A>, initially publicly filed with the SEC on December 23, 2022, as updated by the description
                                            of our Common Stock, filed as&nbsp;<A HREF="https://www.sec.gov/Archives/edgar/data/1959023/000121390026037999/ea028335201ex4-30.htm">Exhibit 4.30</A>&nbsp;to our Annual Report on <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1959023/000121390026037999/ea0283352-10k_renx.htm">Form 10-K</A> for
                                            the year ended December 31, 2025, filed with the SEC on April 1, 2026, including any amendments
                                            or reports filed for the purpose of updating such description. </P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We also incorporate by reference all additional
documents that we file with the SEC under the terms of Section&nbsp;13(a), 13(c), 14 or 15(d)&nbsp;of the Exchange&nbsp;Act that are made
with the SEC (i)&nbsp;on or after the date of the initial filing of the registration statement of which this prospectus forms a part and
prior to effectiveness of such registration statement, and (ii)&nbsp;on or after the date of this prospectus but prior to the termination
of the offering (i.e., until the earlier of the date on which all of the securities registered hereunder have been sold or the registration
statement of which this prospectus forms a part has been withdrawn). Information in such future filings updates and supplements the information
provided in this prospectus. Any statements in any such future filings will automatically be deemed to modify and supersede any information
in any document we previously filed with the SEC that is incorporated or deemed to be incorporated herein by reference to the extent that
statements in the later filed document modify or replace such earlier statements after the date of this prospectus and until the offering
of securities covered by this prospectus has been completed. We are not, however, incorporating, in each case, any documents or information
that we are deemed to furnish and not file in accordance with SEC rules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We will provide, without charge, to each person
to whom a copy of this prospectus or any other supplement or amendment forming a part of the registration statement is delivered, including
any beneficial owner, upon the written or oral request of such person, a copy of any or all of the documents incorporated by reference
herein and therein, including exhibits. Requests should be directed to:</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>RenX Enterprises Corp.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>100 Biscayne Blvd., #1201</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Miami, Florida 33132</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(786) 808-5776</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any statement contained in this prospectus or
in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes
of this prospectus to the extent that a statement contained in this prospectus or in any other subsequently filed document which also
is or is deemed to be incorporated by reference herein modifies or supersedes that statement. Any statement so modified or superseded
shall not be deemed, except as so modified or superseded, to constitute a part of this prospectus.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>PART&nbsp;II</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>INFORMATION NOT REQUIRED IN THE PROSPECTUS</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item 14. Other Expenses of Issuance and Distribution.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth the expenses in
connection with this registration statement. All of such expenses are estimates, other than the filing fee payable to the Securities and
Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD> &nbsp; </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> Amount </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 88%; text-align: left"> SEC registration fee </TD><TD STYLE="width: 1%"> &nbsp; </TD>
    <TD STYLE="width: 1%; text-align: left"> $ </TD><TD STYLE="width: 9%; text-align: right"> 554 </TD><TD STYLE="width: 1%; text-align: left"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"> Legal fees and expenses </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> 100,000 </TD><TD STYLE="text-align: left"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"> Accounting fees and expenses </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> 10,000 </TD><TD STYLE="text-align: left"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt"> Miscellaneous </TD><TD STYLE="padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> 9,446 </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 4pt; padding-left: 7.25pt"> Total: </TD><TD STYLE="padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; text-align: right"> 120,000 </TD><TD STYLE="padding-bottom: 4pt; text-align: left"> &nbsp; </TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item 15. Indemnification of Directors and Officers.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Section 145 of the Delaware
General Corporation Law (the &ldquo;DGCL&rdquo;) empowers a corporation to indemnify its directors and officers and to purchase insurance
with respect to liability arising out of their capacity or status as directors and officers, provided that the person acted in good faith
and in a manner the person reasonably believed to be in our best interests, and, with respect to any criminal action, had no reasonable
cause to believe the person&rsquo;s actions were unlawful. The DGCL further provides that the indemnification permitted thereunder shall
not be deemed exclusive of any other rights to which the directors and officers may be entitled under the corporation&rsquo;s bylaws,
any agreement, a vote of stockholders or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Section&nbsp;102(b)(7)&nbsp;of
the DGCL permits a corporation to provide in its certificate of incorporation that a director or officer of the corporation shall not
be personally liable to the corporation or its stockholders for monetary damages for breach of fiduciary duty as a director or officer,
except (i)&nbsp;for any breach of the director&rsquo;s or officer&rsquo;s duty of loyalty to the corporation or its stockholders; (ii)&nbsp;for
acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law; (iii)&nbsp;a director for payments
of unlawful dividends or unlawful stock repurchases or redemptions; (iv)&nbsp;for any transaction from which the director or officer derived
an improper personal benefit; or (v)&nbsp;an officer in any action by or in the right of the corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Amended and Restated Certificate of Incorporation,
as amended (&ldquo;Charter&rdquo;), and Second Amended and Restated Bylaws provide for the indemnification of our directors and officers
to the fullest extent permitted under Delaware law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, as permitted by Delaware law, our
Charter includes provisions that eliminate the personal liability of our directors for monetary damages resulting from breaches of certain
fiduciary duties as a director, except to the extent such an exemption from liability thereof is not permitted under the DGCL.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As permitted by the DGCL, we have entered into
indemnity agreements with each of our directors and executive officers, that require us to indemnify such persons against any and all
costs and expenses (including attorneys&rsquo;, witness or other professional fees) actually and reasonably incurred by such persons in
connection with any action, suit or proceeding (including derivative actions), whether actual or threatened, to which any such person
may be made a party by reason of the fact that such person is or was a director or officer or is or was acting or serving as our officer,
director, employee or agent or any of our affiliated enterprises. Under these agreements, we are not required to provide indemnification
for certain matters, including:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">indemnification beyond that permitted by the DGCL;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">indemnification for any proceeding with respect to the unlawful payment of remuneration to the director or officer;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">indemnification for certain proceedings involving a final judgment that the director or officer is required to disgorge profits from the purchase or sale of our stock;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">indemnification for proceedings involving a final judgment that the director&rsquo;s or officer&rsquo;s conduct was in bad faith, knowingly fraudulent or deliberately dishonest or constituted willful misconduct or a breach of his or her duty of loyalty, but only to the extent of such specific determination;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">indemnification for proceedings or claims brought by an officer or director against us or any of our directors, officers, employees or agents, except for claims to establish a right of indemnification or proceedings or claims approved by our board of directors or required by law;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">indemnification for settlements the director or officer enters into without our consent; or</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">indemnification in violation of any undertaking required by the Securities Act or in any registration statement filed by us.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 23; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The indemnification agreements also set forth
certain procedures that will apply in the event of a claim for indemnification thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have an insurance policy in place that covers
our officers and directors with respect to certain liabilities, including liabilities arising under the Securities Act or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item 16. Exhibits.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">See the Exhibit&nbsp;Index immediately preceding
the signature page&nbsp;hereto for a list of exhibits filed as part of this registration statement on Form&nbsp;S-3, which Exhibit&nbsp;Index
is incorporated herein by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Item&nbsp;17. Undertakings.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The undersigned Registrant hereby undertakes:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To file, during any period in which offers or
sales are being made, a post-effective amendment to this Registration Statement:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-size: 10pt">(i)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">to include any prospectus required by Section&nbsp;10(a)(3)&nbsp;of the Securities Act;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-size: 10pt">(ii)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">to reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule&nbsp;424(b)&nbsp;if, in the aggregate, the changes in volume and price represent no more than 20 percent change in the maximum aggregate offering price set forth in the &ldquo;Calculation of Registration Fee&rdquo; table in the effective registration statement; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-size: 10pt">(iii)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">to include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>provided</I>,&nbsp;<I>however</I>, that paragraphs
(i), (ii)&nbsp;and (iii)&nbsp;do not apply if the information required to be included in a post-effective amendment by those paragraphs
is contained in reports filed with or furnished to the Commission by the Registrant pursuant to Section&nbsp;13 or Section&nbsp;15(d)&nbsp;of
the Exchange Act that are incorporated by reference in the registration statement, or is contained in a form of prospectus filed pursuant
to Rule&nbsp;424(b)&nbsp;that is part of the registration statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">That, for the purpose of determining any liability
under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities
offered therein, and the offering of such securities at that time shall be deemed to be the initial&nbsp;<I>bona fide</I>&nbsp;offering
thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To remove from registration by means of a post-effective
amendment any of the securities being registered which remain unsold at the termination of the offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">That, for the purpose of determining liability
under the Securities Act to any purchaser:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-size: 10pt">(A)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Each prospectus filed by a Registrant pursuant to Rule&nbsp;424(b)(3)&nbsp;shall be deemed to be part of the registration statement as of the date the filed prospectus was deemed part of and included in the registration statement; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-size: 10pt">(B)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Each prospectus required to be filed pursuant to Rule&nbsp;424(b)(2), (b)(5)&nbsp;or (b)(7)&nbsp;as part of a registration statement in reliance on Rule&nbsp;430B relating to an offering made pursuant to Rule&nbsp;415(a)(1)(i), (vii)&nbsp;or (x)&nbsp;for the purpose of providing the information required by Section&nbsp;10(a)&nbsp;of the Securities Act shall be deemed to be part of and included in the registration statement as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities in the offering described in the prospectus. As provided in Rule&nbsp;430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed to be a new effective date of the registration statement relating to the securities in the registration statement to which that prospectus relates, and the offering of such securities at that time shall be deemed to be the initial&nbsp;<I>bona fide</I>&nbsp;offering thereof.&nbsp;<I>Provided</I>,&nbsp;<I>however</I>, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such effective date.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">That, for purposes of determining any liability
under the Securities Act, each filing of Registrant&rsquo;s annual report pursuant to Section&nbsp;13(a)&nbsp;or 15(d)&nbsp;of the Exchange
Act (and, where applicable, each filing of an employee benefit plan&rsquo;s annual report pursuant to Section&nbsp;15(d)&nbsp;of the Exchange
Act) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the
securities offered therein, and the offering of such securities at that time shall be deemed to be the initial&nbsp;<I>bona fide</I>&nbsp;offering
thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Insofar as indemnification for liabilities arising
under the Securities Act may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions,
or otherwise, the Registrant has been advised that in the opinion of the SEC such indemnification is against public policy as expressed
in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other
than the payment by a Registrant of expenses incurred or paid by a director, officer or controlling person of a Registrant in the successful
defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities
being registered, that Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit
to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities
Act and will be governed by the final adjudication of such issue.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>EXHIBIT&nbsp;INDEX</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 9%; border-bottom: black 1.5pt solid"><FONT STYLE="font-size: 10pt"><B>Exhibit No.</B></FONT></TD>
    <TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 90%; border-bottom: black 1.5pt solid; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Description</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 10pt">3.1</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1959023/000121390023077756/f8k0923ex3-1_safeandgreen.htm"><FONT STYLE="font-size: 10pt">Amended and Restated Certificate of Incorporation (incorporated herein by reference to Exhibit 3.1 to the Form&nbsp;8-K filed by the Registrant with the Securities and Exchange Commission on September&nbsp;19, 2023 (File No.&nbsp;001-41581)).</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-size: 10pt">3.2</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1959023/000121390023077756/f8k0923ex3-2_safeandgreen.htm"><FONT STYLE="font-size: 10pt">Amended and Restated Bylaws (incorporated herein by reference to Exhibit 3.2 to the Form&nbsp;8-K filed by the Registrant with the Securities and Exchange Commission on September&nbsp;19, 2023 (File No.&nbsp;001-41581)).</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 10pt">3.3</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1959023/000121390024086268/ea021699201ex3-1_safe.htm"><FONT STYLE="font-size: 10pt">Certificate of Amendment to the Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.1 of the Current Report on Form&nbsp;8-K filed with the Securities and Exchange Commission on October&nbsp;8, 2024 (File No.&nbsp;001-41581))</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-size: 10pt">3.4</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1959023/000121390024097817/ea022064701ex3-1_safe.htm"><FONT STYLE="font-size: 10pt">Certificate of Amendment to the Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.1 of the Current Report on Form&nbsp;8-K filed with the Securities and Exchange Commission on November&nbsp;14, 2024 (File No.&nbsp;001-41581))</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 10pt">3.5</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1959023/000121390025050980/ea024445101ex3-1_safe.htm"><FONT STYLE="font-size: 10pt">Amendment No. 1 to the Amended and Restated Bylaws (incorporated by reference to Exhibit 3.1 to Form&nbsp;8-K filed by the Registrant with the Securities and Exchange Commission on June&nbsp;4, 2025 (File No.&nbsp;001-41581))</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-size: 10pt">3.6</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1959023/000121390025050980/ea024445101ex4-1_safe.htm"><FONT STYLE="font-size: 10pt">Certificate of Designation of Series&nbsp;A Convertible Preferred Stock (incorporated by reference to Exhibit 4.1 to Form 8-K filed by the Registrant with the Securities and Exchange Commission on June 4, 2025 (File No. 001-41581))</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 10pt">3.7</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1959023/000121390025101289/ea026167501ex3-1_safe.htm"><FONT STYLE="font-size: 10pt">Certificate of Designation of Series&nbsp;B Non-Voting Convertible Preferred Stock&nbsp;(incorporated by reference to Exhibit 3.1 to Form&nbsp;8-K filed by the Registrant with the Securities and Exchange Commission on October 22, 2025 (File No.&nbsp;001-41581))</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-size: 10pt">3.8</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1959023/000121390025101289/ea026167501ex3-2_safe.htm"><FONT STYLE="font-size: 10pt">Certificate of Amendment to Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.2 to Form&nbsp;8-K filed by the Registrant with the Securities and Exchange Commission on October 22, 2025 (File No.&nbsp;001-41581))</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 10pt">3.9</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1959023/000121390025124544/ea027048701ex3-1_renx.htm"><FONT STYLE="font-size: 10pt">Certificate of Amendment to Amended and Restated Certificate of Incorporation</FONT> <FONT STYLE="font-size: 10pt">(incorporated by reference to Exhibit 3.1 to Form 8-K filed by the Registrant with the Securities and Exchange Commission on December 22, 2025 (File No. 001-41581))</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD> <FONT STYLE="font-size: 10pt">3.10</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: justify"> <A HREF="https://www.sec.gov/Archives/edgar/data/1959023/000121390025124544/ea027048701ex3-2_renx.htm"><FONT STYLE="font-size: 10pt">Second
    Amended and Restated Bylaws (incorporated by reference to Exhibit 3.2 to Form 8-K filed by the Registrant with the Securities and
    Exchange Commission on December 22, 2025 (File No. 001-41581))</FONT></A> </TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD> 3.11 </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: justify"> <A HREF="https://www.sec.gov/Archives/edgar/data/1959023/000121390026035974/ea028381101ex3-1.htm">Certificate of Amendment to Amended and Restate Certificate of Incorporation (incorporated by reference to Exhibit 3.1 to Form 8-K filed by the Registrant with the Securities and Exchange Commission on March 30th, 2026 (File No. 001-41581)</A>. </TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-size: 10pt">4.1</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/1959023/000121390026017314/ea027697801ex4-1_renx.htm">Form&nbsp;of Senior Convertible Note, dated February 12, 2026, by and between RenX Enterprises Corp and the purchasers identified on the signature pages&nbsp;thereto (incorporated herein by reference to Exhibit&nbsp;4.1 to the Company&rsquo;s Current Report on Form&nbsp;8-K filed with the Securities and Exchange Commission on February 17, 2026 &ndash; Commission File No.&nbsp;001-41581)</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 10pt">4.2</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/1959023/000121390026017314/ea027697801ex4-2_renx.htm">Form&nbsp;of Warrant (incorporated herein by reference to Exhibit&nbsp;4.2 to the Company&rsquo;s Current Report on Form&nbsp;8-K filed with the Securities and Exchange Commission on February 17, 2026 &ndash; Commission File No.&nbsp;001-41581)</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-size: 10pt">4.3</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/1959023/000121390026017314/ea027697801ex4-3_renx.htm">Form&nbsp;of Warrant (incorporated herein by reference to Exhibit&nbsp;4.3 to the Company&rsquo;s Current Report on Form&nbsp;8-K filed with the Securities and Exchange Commission on February 17, 2026 &ndash; Commission File No.&nbsp;001-41581)</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 10pt">5.1*</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="ea028515701ex5-1.htm"><FONT STYLE="font-size: 10pt">Opinion of Blank Rome LLP</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-size: 10pt">10.1</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/1959023/000121390026017314/ea027697801ex1-1_renx.htm">Placement Agency Agreement, dated February 12, 2026, between the Company and Dawson James Securities, Inc. (incorporated herein by reference to Exhibit&nbsp;1.1 to the Company&rsquo;s Current Report on Form&nbsp;8-K filed with the Securities and Exchange Commission on February 17, 2026 &ndash; Commission File No.&nbsp;001-41581)</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 10pt">10.2#</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/1959023/000121390026017314/ea027697801ex10-1_renx.htm">Form&nbsp;of Securities Purchase Agreement, dated February 12, 2026, by and between RenX Enterprises Corp and the purchasers identified on the signature pages&nbsp;thereto (incorporated herein by reference to Exhibit&nbsp;10.1 to the Company&rsquo;s Current Report on Form&nbsp;8-K filed with the Securities and Exchange Commission on February 17, 2026 &ndash; Commission File No.&nbsp;001-41581)</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-size: 10pt">10.3</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/1959023/000121390026017314/ea027697801ex10-2_renx.htm">Form&nbsp;of Registration Rights Agreement, dated February 12, 2026, by and between RenX Enterprises Corp and the purchasers identified on the signature pages&nbsp;thereto (incorporated herein by reference to Exhibit&nbsp;10.2 to the Company&rsquo;s Current Report on Form&nbsp;8-K filed with the Securities and Exchange Commission on February 17, 2026 &ndash; Commission File No.&nbsp;001-41581)</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 10pt">23.1*</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="ea028515701ex23-1.htm"><FONT STYLE="font-size: 10pt">Consent of M&amp;K, CPAs, independent registered public accounting firm for the Registrant</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-size: 10pt">23.2*</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="ea028515701ex23-2.htm"><FONT STYLE="font-size: 10pt">Consent of Independent Auditors for Resource Group US Holdings LLC, M&amp;K CPAS PLLC</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 10pt">23.3*</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="ea028515701ex5-1.htm"><FONT STYLE="font-size: 10pt">Consent of Blank Rome LLP (included in Exhibit&nbsp;5.1)</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD> <FONT STYLE="font-size: 10pt">24.1**</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: justify"> <A HREF="https://www.sec.gov/Archives/edgar/data/1959023/000121390026017446/ea0277284-s3_renx.htm#ren_014"><FONT STYLE="font-size: 10pt">Powers
    of Attorney (included on the signature page&nbsp;of the initial Registration Statement)</FONT></A> </TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD> <FONT STYLE="font-size: 10pt">107**</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: justify"> <FONT STYLE="font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/1959023/000121390026017446/ea027728401ex-fee_renx.htm">Calculation of Filing Fee Table</A></FONT> </TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px; text-align: justify"><FONT STYLE="font-size: 10pt">*</FONT></TD>
    <TD STYLE="padding-left: 1.2pt; text-align: justify; text-indent: -1.2pt"><FONT STYLE="font-size: 10pt">Filed herewith.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"> ** </TD>
    <TD STYLE="padding-left: 1.2pt; text-align: justify; text-indent: -1.2pt"> Previously filed. </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">#</FONT></TD>
    <TD STYLE="padding-left: 1.2pt; text-align: justify; text-indent: -1.2pt"><FONT STYLE="font-size: 10pt">Schedules have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The Company agrees to furnish supplementally a copy of any omitted exhibit to the SEC upon request.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> Pursuant to the requirements of the Securities
Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for
filing on Form S-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized,
in the City of Miami, State of Florida, on the 8<SUP>th</SUP> day of April, 2026. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt"><B>RenX Enterprises Corp.</B></FONT></TD></TR>
  <TR>
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 36%">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1.5pt solid"><FONT STYLE="font-size: 10pt">/s/ David Villarreal</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">David Villarreal</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B></B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> Pursuant to the requirements of the Securities
Act of 1933, as amended, this Amendment No. 1 Registration Statement on Form S-3 has been signed by the following persons in the capacities
and on the dates indicated. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 33%; border-bottom: black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Person</B>&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; text-align: center"> &nbsp; </TD>
    <TD STYLE="width: 39%; border-bottom: black 1.5pt solid; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Capacity</B></FONT> </TD>
    <TD STYLE="width: 1%; text-align: center"> &nbsp; </TD>
    <TD STYLE="width: 26%; border-bottom: black 1.5pt solid; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Date</B></FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: justify"> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: justify"> &nbsp; </TD>
    <TD STYLE="text-align: center"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ David
    Villarreal&nbsp;</FONT> </TD>
    <TD STYLE="text-align: justify"> &nbsp; </TD>
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer and Director</FONT> </TD>
    <TD STYLE="text-align: justify"> &nbsp; </TD>
    <TD STYLE="text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">April 8, 2026</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">David Villarreal&nbsp;</FONT> </TD>
    <TD STYLE="text-align: justify"> &nbsp; </TD>
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal Executive Officer)&nbsp;</FONT> </TD>
    <TD STYLE="text-align: justify"> &nbsp; </TD>
    <TD STYLE="text-align: center"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: justify"> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: justify"> &nbsp; </TD>
    <TD STYLE="text-align: center"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Nicolai
    Brune&nbsp;</FONT> </TD>
    <TD STYLE="text-align: justify"> &nbsp; </TD>
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer&nbsp;</FONT> </TD>
    <TD STYLE="text-align: justify"> &nbsp; </TD>
    <TD STYLE="text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">April 8, 2026</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nicolai Brune&nbsp;</FONT> </TD>
    <TD STYLE="text-align: justify"> &nbsp; </TD>
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal Financial and Accounting Officer)&nbsp;</FONT> </TD>
    <TD STYLE="text-align: justify"> &nbsp; </TD>
    <TD STYLE="text-align: center"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: justify"> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: justify"> &nbsp; </TD>
    <TD STYLE="text-align: center"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT> </TD>
    <TD STYLE="text-align: justify"> &nbsp; </TD>
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT> </TD>
    <TD STYLE="text-align: justify"> &nbsp; </TD>
    <TD STYLE="text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">April 8, 2026</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Peter G. DeMaria&nbsp;</FONT> </TD>
    <TD STYLE="text-align: justify"> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: justify"> &nbsp; </TD>
    <TD STYLE="text-align: center"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: justify"> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: justify"> &nbsp; </TD>
    <TD STYLE="text-align: center"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT> </TD>
    <TD STYLE="text-align: justify"> &nbsp; </TD>
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT> </TD>
    <TD STYLE="text-align: justify"> &nbsp; </TD>
    <TD STYLE="text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">April 8, 2026</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">John Scott Magrane, Jr.</FONT> </TD>
    <TD STYLE="text-align: justify"> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: justify"> &nbsp; </TD>
    <TD STYLE="text-align: center"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: justify"> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: justify"> &nbsp; </TD>
    <TD STYLE="text-align: center"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT> </TD>
    <TD STYLE="text-align: justify"> &nbsp; </TD>
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT> </TD>
    <TD STYLE="text-align: justify"> &nbsp; </TD>
    <TD STYLE="text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">April 8, 2026</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Christopher Melton&nbsp;</FONT> </TD>
    <TD STYLE="text-align: justify"> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: justify"> &nbsp; </TD>
    <TD STYLE="text-align: center"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: justify"> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: justify"> &nbsp; </TD>
    <TD STYLE="text-align: center"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1.5pt solid"> &nbsp; </TD>
    <TD STYLE="text-align: justify"> &nbsp; </TD>
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT> </TD>
    <TD STYLE="text-align: justify"> &nbsp; </TD>
    <TD STYLE="text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">April 8, 2026</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jeffrey Tweedy&nbsp;</FONT> </TD>
    <TD STYLE="text-align: justify"> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: justify"> &nbsp; </TD>
    <TD STYLE="text-align: center"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: justify"> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: justify"> &nbsp; </TD>
    <TD STYLE="text-align: center"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT> </TD>
    <TD STYLE="text-align: justify"> &nbsp; </TD>
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT> </TD>
    <TD STYLE="text-align: justify"> &nbsp; </TD>
    <TD STYLE="text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">April 8, 2026</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bjarne Borg &nbsp;</FONT> </TD>
    <TD STYLE="text-align: justify"> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: justify"> &nbsp; </TD>
    <TD STYLE="text-align: center"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: justify"> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: justify"> &nbsp; </TD>
    <TD STYLE="text-align: center"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT> </TD>
    <TD STYLE="text-align: justify"> &nbsp; </TD>
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT> </TD>
    <TD STYLE="text-align: justify"> &nbsp; </TD>
    <TD STYLE="text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">April 8, 2026</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">James D.&nbsp;Burnham</FONT> </TD>
    <TD STYLE="text-align: justify"> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: justify"> &nbsp; </TD>
    <TD STYLE="text-align: center"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: justify"> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: justify"> &nbsp; </TD>
    <TD STYLE="text-align: center"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT> </TD>
    <TD STYLE="text-align: justify"> &nbsp; </TD>
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT> </TD>
    <TD STYLE="text-align: justify"> &nbsp; </TD>
    <TD STYLE="text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">April 8, 2026</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD> Anthony M.&nbsp;Cialone &nbsp; </TD>
    <TD STYLE="text-align: justify"> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: justify"> &nbsp; </TD>
    <TD STYLE="text-align: center"> &nbsp; </TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*By:</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 37%"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    David Villarreal</FONT> </TD>
    <TD STYLE="width: 60%"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">David Villarreal</FONT> </TD>
    <TD> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attorney-in-Fact</FONT> </TD>
    <TD> &nbsp; </TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 27; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></FONT></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>ea028515701ex5-1.htm
<DESCRIPTION>OPINION OF BLANK ROME LLP
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Exhibit 5.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="ea028515701_ex5-1img1.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">1271 Avenue of the Americas | New York, NY 10020</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">blankrome.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-align: right; text-indent: 0.5in">April 8, 2026</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-align: right; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Board of Directors</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">RenX Enterprises Corp.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">100 Biscayne Blvd., #1201</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Miami, Florida 33132</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dear Ladies &amp; Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">This opinion is furnished to
you in connection with a Registration Statement on Form S-3 (the &ldquo;Registration Statement&rdquo;) filed with the Securities and Exchange
Commission (the &ldquo;Commission&rdquo;) under the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;), which registers
the resale by the holders thereof of an aggregate of 2,290,310 shares (the &ldquo;Shares&rdquo;) of common stock, par value $0.001 per
share (the &ldquo;Common Stock&rdquo;), of RenX Enterprises Corp., a Delaware corporation (the &ldquo;Company&rdquo;), which includes
(i) </FONT>up to an aggregate of 1,215,046 shares of Common Stock issuable upon <FONT STYLE="background-color: white">the conversion of
certain senior convertible promissory notes in the aggregate principal amount of $6,042,985.39 (the &ldquo;Notes&rdquo;)</FONT> at the
conversion price of $5.62 per share (assuming the Notes accrued interest at 12% for a period of thirteen (13) months), without giving
effect to any default interest or penalties which may accrue thereunder<FONT STYLE="background-color: white">, and (ii) up to </FONT>1,075,264
shares of Common Stock issuable upon <FONT STYLE="background-color: white">the exercise of certain accompanying warrants (the &ldquo;Warrants&rdquo;),</FONT>
which Warrants are exercisable immediately upon issuance<FONT STYLE="background-color: white">. The Notes and Warrants were issued and
sold to the Selling Stockholders in a private placement offering, pursuant to the terms of that certain Securities Purchase Agreement,
dated as of February 12, 2026 (the &ldquo;Purchase Agreement&rdquo;), between the Company and the Selling Stockholders. </FONT>Except
as otherwise provided herein, all capitalized terms not otherwise defined herein shall have the meanings ascribed to them in the Purchase
Agreement. <FONT STYLE="background-color: white">This opinion is being furnished in accordance with the requirements of Item 601(b)(5)
of Regulation S-K under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">In rendering the opinions set
forth herein, we have examined originals or copies, certified or otherwise identified to our satisfaction, of (i) the Registration Statement
and all exhibits thereto; (ii) the Purchase Agreement; (iii) the form of Notes; (iv) the form of Warrants; (v) resolutions adopted by
the Board of Directors of the Company (the &ldquo;Board&rdquo;); (vi) the amended and restated certificate of incorporation of the Company,
as amended; (vii) the second amended and restated bylaws of the Company; and (vii) such other corporate records, agreements, certificates,
including, but not limited to, certificates or comparable documents of public officials and of officers and representatives of the Company,
statutes and other instruments and documents as we considered relevant and necessary as a basis for the opinions hereinafter expressed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">In rendering
this opinion, we have assumed, without inquiry, (i) the authenticity of all documents submitted to us as originals; (ii) the conformity
to the original documents of all documents submitted to us as facsimile, electronic, certified or photostatic copies, and the authenticity
of the originals of such copies; (iii) the legal capacity of all natural persons and the genuineness of all signatures on the Registration
Statement and all documents submitted to us; and (iv) that the books and records of the Company are maintained in accordance with proper
corporate procedures.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><IMG SRC="ea028515701_ex5-1img1.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Board of Directors</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">RenX Enterprises Corp.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">April 8, 2026</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Page 2</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">With respect
to the Shares we express no opinion to the extent that future issuances of securities of the Company and/or adjustments to outstanding
securities of the Company cause the Notes and/or the Warrants to be exercisable for more shares of Common Stock than the number that remain
available for issuance. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">Based upon the foregoing, we
are of the opinion that the Shares have been duly authorized and, when issued upon the conversion of the Notes in accordance with the
terms of the Notes or upon exercise of the Warrants in accordance with the terms of the Warrants, the Shares will be validly issued, fully
paid and non-assessable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">The opinions
expressed herein are limited exclusively to the General Corporation Law of the State of Delaware (the &ldquo;DGCL&rdquo;) and applicable
provisions of the Delaware Constitution and reported judicial decisions interpreting the DGCL and such provisions of the Delaware Constitution
and we have not considered, and express no opinion on, any other laws or the laws of any other jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">We hereby
consent to the filing of this opinion as Exhibit 5.1 to the Registration Statement and to the reference to our firm under the caption
&ldquo;Legal Matters&rdquo; in the Registration Statement. In giving our consent, we do not thereby admit that we are in the category
of persons whose consent is required under Section 7 of the Securities Act or the rules and regulations of the Commission thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 40%"><FONT STYLE="font-size: 10pt">Very truly yours,</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 10pt">/s/ BLANK ROME LLP</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">BLANK ROME LLP</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>ea028515701ex23-1.htm
<DESCRIPTION>CONSENT OF M&K, CPAS, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE REGISTRANT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 23.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We hereby consent to the incorporation by reference in the Prospectus
constituting a part of this Registration Statement on Form S-3 of our report dated March 31, 2025, relating to the audit of the financial
statements of RenX Enterprises Corp. (fka Safe and Green Development Corporation) as of December 31, 2025 and December 31, 2024 and for
the annual periods then ended, in the Annual Report filed by RenX Enterprises Corp. on Form 10-K for the year ended December 31, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We also consent to the reference to our Firm under
the caption Experts in the Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">/s/ M&amp;K CPAs, PLLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Woodlands, TX</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">April 8, 2026</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>4
<FILENAME>ea028515701ex23-2.htm
<DESCRIPTION>CONSENT OF INDEPENDENT AUDITORS FOR RESOURCE GROUP US HOLDINGS LLC, M&K CPAS PLLC
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 23.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We hereby consent to the incorporation by reference
in the Prospectus constituting a part of this Registration Statement on Form S-3 of RenX Enterprises Corp. (fka Safe and Green Development
Corporation) of our report dated August 12, 2025, relating to the audit of the financial statements of Resource Group US Holdings LLC
as of December 31, 2024 and 2023, and for the two-year period ended December 31, 2024, which appeared in RenX Enterprises Corp.&rsquo;s
Current Report on Form 8-K filed on August 12, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;We also consent to the reference to our
Firm under the caption &ldquo;Experts&rdquo; in the Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">/s/ M&amp;K CPA&rsquo;s, PLLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Woodlands, TX</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">April 8, 2026</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>ea028515701_img1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ea028515701_img1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !V '8# 2(  A$! Q$!_\0
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##__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>ea028515701_ex5-1img1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ea028515701_ex5-1img1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  8 -@# 2(  A$! Q$!_\0
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M 3#HOB1M0A?YX+C6D2R\3")@/+BUN.(#,; ?E%_P2U_;G_89^!_P6\;?$O\
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M;>'?V7_C+XETW^R?$5[:3Z9(NJZ9X6DM6G>*%S/!D2P.-CK]UF_22^_X+ _
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MY$XQ779=]S])S_P6)_9< )/PY_;#P 2?^,0/CIGCG_H4_K7S=^WKKOB#]O\
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MQ+H]OX/\4:)H^C:3=:SK-S<^'_&_AZ^N?[*T^PM[J^GNDTZ.]9ELX7G^S_:
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MHAD\0^"/'G@S3?$&G?V?JK1R7BZ==R'^SUD^SI?WPC:8L^(O_!5*'XLZ5=^
M_P#@GQ\(/BC^TE\6?$D+Z3H'B^3X?^)_!GP6\#W=ZI@7Q'XS\<>---T"PEM-
M),B7ATNT8C4 @MY+VU$@8E%?-//<R6>2X>]M%T%.5#Z[[./UWD5'GOS7]C[6
MWN^U]ES7]^W.?T6_!S@"/A'_ ,1P_LBL\U_LY9[_ *I/'XA\(_77C8T_8^PL
MLU>7JJ_;?4'F7LN1?574^K:'M7[(/['%W^R)^RE\1O#?B?79/'WQM^*4/CCX
ME_&SQO"DT[^*OB1XGTF[>]M]+66)+VXTS2QY>G:89(8Y]0E%UJ9M+2;47LX?
M)?\ @A[X8U_PY_P3V\!Z'XL\.Z_X8U5?&7Q0>YT7Q/H>IZ!JL=O=>,M5>&2?
M2]8M+2]CBN(G$D+R6X2>)@\19""2BOIX86EA<QRZA13C2HY?C:<(MWNG4P\I
M2DWK*<I.4I2;O*4I-W;/YTQ/$F:9_P "<?9GFE6-?'9OQUPCF.)KQA[+DJ4<
MOSRG0H8:G3<:5#"T*,:.'P]"$5&A0P]"E2Y8P][\O/BE^S?^T-X6^/'Q%_X)
M:?#_ ,,>+8/V5OVF_P!H3PE\>8/B!INDZO\ \(UX'^#MZ;GQ5\4_ ":REG)H
MU@$\0>'8;:PL+C4[:X>?3M-C6SE7Q."O[7?\%'_!'V#_ ()P_M'> / 7AJ\N
M(--^"LWAOPKX4\,:5>:E>+9Z6NE6.FZ5I&D:;!<WMT8+*VCB@MK2WED$<6%C
MPI-%%<6'P=/#X;B%1E.2B\7A:7.T_8X:GAY5J>'IV2M3A4Q5644[O6*O:*2^
MOX@XKQ^;9[X)3JX?!X>3I<.<29@\-"I#^V.(<7G-#*L7G69.523JX_%8'AO+
M*%:I!PBU"M.,8U*]6=3X>_:Y\'>+]6_X(6>%/"&E^$_$VH^+3\#OV=;%O"MC
MX?UB\\3)>6FK> _MMI+X>MK*;6([FQ$,[:A;O9+-9)#.US'$L,FWV?X6?\%5
M?V??!_PS^'OA35OAQ^U8NK>&O!7A?0-22W_99^-$\*WVD:)96%VL4R>$WCE5
M;B&51)&[1NH#1LR%68HKR<US+$Y1C</4POLW*OE6 I3]K#G2C23E%QM*+3O)
MWO=-6T1^M>&_A[P[XH\*\183B6&.A3R?Q.XPS'"2RW&2PD_;9G[.GB(56Z5>
M-2FHT8>S7+&<6FW*5[+OO^'O/[-HZ_#G]K,?]VI_&O\ ^9*BBBO/_P!<,V_E
<PG_@E_\ RP^SC]%GPR:O[3B3_P /"_\ F(__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
